data_2n7i_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n7i _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.474 HD13 ' N ' ' A' ' 225' ' ' CYS . 2.7 pp . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 121.059 0.456 . . . . 1.1699999999999999 110.232 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . 0.474 ' N ' HD13 ' A' ' 224' ' ' ILE . 54.8 m -66.99 -34.57 78.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.817 -0.629 . . . . 1.8899999999999999 110.288 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 6.2 mp -69.12 -52.47 27.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.661 -0.7 . . . . 1.1899999999999999 111.921 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.515 HG13 ' N ' ' A' ' 228' ' ' ILE . 9.9 pt -53.58 -36.0 27.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 111.945 0.35 . . . . 1.1899999999999999 111.945 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.515 ' N ' HG13 ' A' ' 227' ' ' ILE . 84.2 mt -61.7 -37.33 77.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.162 0.506 . . . . 1.1100000000000001 110.366 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 75.1 t -61.96 -49.05 85.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.45 -0.795 . . . . 1.1399999999999999 111.268 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -71.61 -37.11 70.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.161 0.505 . . . . 0.67000000000000004 110.951 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -62.45 -7.18 4.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.573 -0.74 . . . . 1.0800000000000001 111.801 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 232' ' ' VAL . 78.0 t -117.84 -1.44 9.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.683 0.754 . . . . 1.2 110.283 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.15 -3.69 11.05 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.073 -1.084 . . . . 1.1000000000000001 108.073 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 7.7 mp -120.07 10.57 11.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 113.84 -1.527 . . . . 1.1799999999999999 108.343 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.2 mptt . . . . . 0 N--CA 1.452 -0.353 0 CA-C-N 115.019 -0.992 . . . . 1.1499999999999999 111.472 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 CA--C 1.524 -0.041 0 CA-C-O 120.958 0.409 . . . . 1.1699999999999999 110.753 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 51.1 t -66.46 -37.47 85.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.058 -0.519 . . . . 1.8899999999999999 110.56 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 9.6 mp -66.17 -52.53 47.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.895 -0.593 . . . . 1.1899999999999999 111.655 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.496 HG13 ' N ' ' A' ' 228' ' ' ILE . 17.6 pt -55.46 -35.81 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.638 -0.256 . . . . 1.1899999999999999 111.655 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.496 ' N ' HG13 ' A' ' 227' ' ' ILE . 82.9 mt -62.24 -39.06 82.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.08 0.467 . . . . 1.1100000000000001 110.271 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 77.7 t -57.09 -49.95 77.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.499 -0.773 . . . . 1.1399999999999999 110.794 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.4 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 3.5 m-90 -72.45 -37.93 68.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.67000000000000004 110.882 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -64.93 -7.16 10.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.642 -0.708 . . . . 1.0800000000000001 111.793 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 232' ' ' VAL . 74.6 t -117.77 -0.95 8.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.836 0.827 . . . . 1.2 110.107 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.04 -4.49 11.03 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.206 -1.035 . . . . 1.1000000000000001 108.206 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 6.8 mp -119.93 10.77 11.62 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 113.843 -1.526 . . . . 1.1799999999999999 108.319 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.1 mptt . . . . . 0 N--CA 1.45 -0.435 0 CA-C-N 115.061 -0.972 . . . . 1.1499999999999999 111.29 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.466 HD13 ' N ' ' A' ' 225' ' ' CYS . 2.6 pp . . . . . 0 CA--C 1.523 -0.091 0 CA-C-O 120.991 0.424 . . . . 1.1699999999999999 110.21 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . 0.466 ' N ' HD13 ' A' ' 224' ' ' ILE . 58.2 m -66.96 -34.38 77.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.88 -0.6 . . . . 1.8899999999999999 110.26 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 7.0 mp -70.91 -48.25 54.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.635 -0.712 . . . . 1.1899999999999999 112.198 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.499 HG13 ' N ' ' A' ' 228' ' ' ILE . 12.9 pt -56.95 -36.16 49.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 111.98 0.363 . . . . 1.1899999999999999 111.98 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.499 ' N ' HG13 ' A' ' 227' ' ' ILE . 81.3 mt -61.62 -37.65 78.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.187 0.518 . . . . 1.1100000000000001 110.3 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 79.6 t -58.68 -49.86 81.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.444 -0.798 . . . . 1.1399999999999999 111.036 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.403 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 2.1 m-90 -72.05 -38.92 69.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.07 0.462 . . . . 0.67000000000000004 110.863 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -64.16 -8.08 11.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.705 -0.68 . . . . 1.0800000000000001 111.657 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . 0.484 ' O ' HG11 ' A' ' 232' ' ' VAL . 65.4 t -117.95 -0.44 8.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.9 0.857 . . . . 1.2 110.042 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.22 -2.93 11.08 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.14 -1.059 . . . . 1.1000000000000001 108.14 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 8.0 mp -120.02 8.74 11.06 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 113.917 -1.492 . . . . 1.1799999999999999 108.09 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.2 mptt . . . . . 0 N--CA 1.451 -0.408 0 CA-C-N 114.712 -1.131 . . . . 1.1499999999999999 111.28 -178.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.41 HD11 ' N ' ' A' ' 225' ' ' CYS . 2.7 pp . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 121.011 0.434 . . . . 1.1699999999999999 110.244 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . 0.41 ' N ' HD11 ' A' ' 224' ' ' ILE . 35.0 t -66.94 -35.11 79.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.963 -0.562 . . . . 1.8899999999999999 110.147 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 7.4 mp -63.64 -50.5 69.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.575 -0.739 . . . . 1.1899999999999999 111.877 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.499 HG13 ' N ' ' A' ' 228' ' ' ILE . 11.5 pt -59.24 -35.99 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.798 -0.183 . . . . 1.1899999999999999 111.484 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.499 ' N ' HG13 ' A' ' 227' ' ' ILE . 82.7 mt -61.6 -37.79 78.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.194 0.521 . . . . 1.1100000000000001 110.223 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 65.4 t -56.79 -48.85 80.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.453 -0.794 . . . . 1.1399999999999999 110.873 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.415 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 2.4 m-90 -72.36 -40.23 67.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.047 -0.524 . . . . 0.67000000000000004 110.845 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -66.52 -7.27 18.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.7 -0.682 . . . . 1.0800000000000001 111.616 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 232' ' ' VAL . 71.3 t -118.0 -0.06 8.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.931 0.872 . . . . 1.2 109.983 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.29 -3.85 10.97 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.123 -1.065 . . . . 1.1000000000000001 108.123 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.3 mp -119.97 9.92 11.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 113.937 -1.483 . . . . 1.1799999999999999 108.273 178.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.2 mptt . . . . . 0 N--CA 1.451 -0.413 0 CA-C-N 115.02 -0.991 . . . . 1.1499999999999999 111.832 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.6 pp . . . . . 0 C--O 1.23 0.055 0 CA-C-O 121.023 0.439 . . . . 1.1699999999999999 110.453 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . 0.42 ' N ' HD12 ' A' ' 224' ' ' ILE . 38.6 t -67.55 -35.01 78.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.972 -0.558 . . . . 1.8899999999999999 110.328 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.31 -49.87 57.4 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.555 -0.748 . . . . 1.1899999999999999 112.214 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.51 HG13 ' N ' ' A' ' 228' ' ' ILE . 4.4 pt -53.76 -36.25 29.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.593 0.235 . . . . 1.1899999999999999 111.433 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.51 ' N ' HG13 ' A' ' 227' ' ' ILE . 65.6 mt -66.22 -38.0 80.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.073 0.463 . . . . 1.1100000000000001 110.146 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 225' ' ' CYS . 79.0 t -59.05 -46.05 92.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.646 -0.706 . . . . 1.1399999999999999 110.717 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.448 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 1.9 m-90 -71.95 -41.66 67.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.08 0.467 . . . . 0.67000000000000004 110.2 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -64.79 -8.3 14.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.66 -0.7 . . . . 1.0800000000000001 111.295 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 232' ' ' VAL . 60.7 t -118.31 -1.06 8.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.849 0.833 . . . . 1.2 109.9 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.09 -1.97 11.31 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.272 -1.01 . . . . 1.1000000000000001 108.272 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 8.6 mp -120.46 7.78 10.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 113.907 -1.497 . . . . 1.1799999999999999 107.805 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.3 mptt . . . . . 0 N--CA 1.45 -0.47 0 CA-C-N 114.852 -1.067 . . . . 1.1499999999999999 112.009 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.46 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.7 pp . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.909 0.385 . . . . 1.1699999999999999 110.471 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . 0.46 ' N ' HD12 ' A' ' 224' ' ' ILE . 51.2 t -67.4 -34.94 78.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.021 -0.536 . . . . 1.8899999999999999 110.461 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.442 ' HB3' ' HZ3' ' A' ' 230' ' ' TRP . 8.2 mp -70.21 -51.91 27.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.643 -0.708 . . . . 1.1899999999999999 112.105 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 228' ' ' ILE . 4.8 pt -53.59 -36.24 27.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 111.729 0.27 . . . . 1.1899999999999999 111.729 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.5 ' N ' HG13 ' A' ' 227' ' ' ILE . 83.4 mt -65.04 -37.5 80.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.042 0.448 . . . . 1.1100000000000001 110.261 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 78.6 t -60.58 -48.18 89.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.562 -0.745 . . . . 1.1399999999999999 111.075 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.442 ' HZ3' ' HB3' ' A' ' 226' ' ' LEU . 1.8 m-90 -71.85 -40.26 69.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.015 0.436 . . . . 0.67000000000000004 110.634 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.15 -8.16 7.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.808 -0.633 . . . . 1.0800000000000001 111.581 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 232' ' ' VAL . 63.3 t -118.12 -1.82 9.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.794 0.807 . . . . 1.2 110.279 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -117.96 -2.17 11.34 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.263 -1.014 . . . . 1.1000000000000001 108.263 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.8 mp -119.99 8.3 11.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 113.801 -1.545 . . . . 1.1799999999999999 107.956 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 1.3 mptt . . . . . 0 N--CA 1.452 -0.355 0 CA-C-N 114.688 -1.142 . . . . 1.1499999999999999 111.018 -178.529 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.434 ' HA ' HG12 ' A' ' 227' ' ' ILE . 2.7 pp . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 121.136 0.494 . . . . 1.1699999999999999 110.184 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . 0.432 ' N ' HD11 ' A' ' 224' ' ' ILE . 19.0 m -66.63 -34.42 77.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.576 -0.738 . . . . 1.8899999999999999 110.276 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.45 -53.07 21.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.672 -0.695 . . . . 1.1899999999999999 111.733 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.502 HG13 ' N ' ' A' ' 228' ' ' ILE . 10.9 pt -55.19 -36.2 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.154 0.427 . . . . 1.1899999999999999 112.154 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.502 ' N ' HG13 ' A' ' 227' ' ' ILE . 81.0 mt -62.44 -37.75 79.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.109 0.48 . . . . 1.1100000000000001 110.438 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 67.8 t -59.1 -50.01 81.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.46 -0.791 . . . . 1.1399999999999999 111.063 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 3.1 m-90 -71.77 -36.39 70.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.67000000000000004 110.901 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -65.28 -7.04 11.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.648 -0.705 . . . . 1.0800000000000001 111.604 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . 0.479 ' O ' HG12 ' A' ' 232' ' ' VAL . 71.6 t -117.87 -0.78 8.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.892 0.854 . . . . 1.2 109.953 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.01 -3.56 11.12 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.19 -1.041 . . . . 1.1000000000000001 108.19 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 7.5 mp -120.02 9.03 11.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 113.961 -1.472 . . . . 1.1799999999999999 108.278 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.452 -0.362 0 CA-C-N 114.983 -1.008 . . . . 1.1499999999999999 111.656 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.415 HD11 ' N ' ' A' ' 225' ' ' CYS . 2.7 pp . . . . . 0 CA--C 1.521 -0.152 0 CA-C-O 121.163 0.506 . . . . 1.1699999999999999 110.085 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . 0.426 ' HA ' HD11 ' A' ' 228' ' ' ILE . 33.6 m -66.55 -34.83 78.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.708 -0.678 . . . . 1.8899999999999999 110.273 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.1 mp -62.12 -55.23 30.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.688 -0.687 . . . . 1.1899999999999999 111.687 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.505 HG13 ' N ' ' A' ' 228' ' ' ILE . 16.2 pt -55.67 -35.78 40.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.486 -0.325 . . . . 1.1899999999999999 111.806 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.505 ' N ' HG13 ' A' ' 227' ' ' ILE . 83.8 mt -62.14 -39.67 84.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.149 0.5 . . . . 1.1100000000000001 110.248 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 79.2 t -56.41 -48.25 80.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.485 -0.779 . . . . 1.1399999999999999 110.663 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.422 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 3.0 m-90 -72.43 -39.79 67.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.003 -0.544 . . . . 0.67000000000000004 110.861 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -67.14 -7.21 21.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.614 -0.721 . . . . 1.0800000000000001 111.493 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . 0.479 ' O ' HG12 ' A' ' 232' ' ' VAL . 62.8 t -117.96 -0.06 8.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.836 0.827 . . . . 1.2 109.95 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.18 -4.31 10.99 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.097 -1.075 . . . . 1.1000000000000001 108.097 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.1 mp -119.94 9.45 11.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.873 -1.512 . . . . 1.1799999999999999 108.342 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.452 -0.342 0 CA-C-N 114.884 -1.053 . . . . 1.1499999999999999 111.039 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.498 ' HA ' HG12 ' A' ' 227' ' ' ILE . 2.6 pp . . . . . 0 N--CA 1.458 -0.073 0 CA-C-O 120.92 0.39 . . . . 1.1699999999999999 110.416 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . 0.434 ' N ' HD11 ' A' ' 224' ' ' ILE . 53.0 t -67.12 -35.41 79.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.509 . . . . 1.8899999999999999 110.297 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 8.3 mp -71.41 -49.05 45.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.731 -0.668 . . . . 1.1899999999999999 111.8 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.52 HG13 ' N ' ' A' ' 228' ' ' ILE . 12.5 pt -57.31 -36.1 51.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.668 -0.242 . . . . 1.1899999999999999 111.572 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.52 ' N ' HG13 ' A' ' 227' ' ' ILE . 81.5 mt -63.14 -37.61 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.147 0.498 . . . . 1.1100000000000001 110.165 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 225' ' ' CYS . 74.9 t -60.82 -47.99 90.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.524 -0.762 . . . . 1.1399999999999999 110.949 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.424 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 2.2 m-90 -72.22 -40.94 67.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.049 0.452 . . . . 0.67000000000000004 110.871 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -64.15 -7.73 9.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.672 -0.695 . . . . 1.0800000000000001 111.562 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . 0.465 ' O ' HG12 ' A' ' 232' ' ' VAL . 68.3 t -118.02 -0.71 8.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.769 0.795 . . . . 1.2 110.133 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.25 -3.99 10.98 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.127 -1.064 . . . . 1.1000000000000001 108.127 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.4 mp -119.79 8.95 11.23 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 113.894 -1.503 . . . . 1.1799999999999999 108.119 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.1 mptt . . . . . 0 N--CA 1.45 -0.426 0 CA-C-N 114.911 -1.041 . . . . 1.1499999999999999 111.187 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.41 HD13 ' N ' ' A' ' 225' ' ' CYS . 2.6 pp . . . . . 0 CA--C 1.524 -0.041 0 CA-C-O 120.93 0.395 . . . . 1.1699999999999999 110.667 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . 0.41 ' N ' HD13 ' A' ' 224' ' ' ILE . 51.5 t -67.36 -35.15 78.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 1.8899999999999999 110.566 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 8.8 mp -67.1 -50.29 62.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.764 -0.653 . . . . 1.1899999999999999 111.932 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.53 HG13 ' N ' ' A' ' 228' ' ' ILE . 10.2 pt -55.82 -36.22 42.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 111.593 0.22 . . . . 1.1899999999999999 111.593 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.53 ' N ' HG13 ' A' ' 227' ' ' ILE . 75.2 mt -62.55 -37.97 80.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.052 0.453 . . . . 1.1100000000000001 110.166 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 75.4 t -58.06 -48.05 85.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.492 -0.776 . . . . 1.1399999999999999 110.673 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.428 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 2.5 m-90 -71.95 -38.85 69.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.082 -0.508 . . . . 0.67000000000000004 110.522 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.6 -7.37 14.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.719 -0.673 . . . . 1.0800000000000001 111.472 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 232' ' ' VAL . 68.0 t -117.57 -1.28 9.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.75 0.786 . . . . 1.2 109.938 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.28 -3.62 10.99 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.087 -1.079 . . . . 1.1000000000000001 108.087 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.0 mp -120.17 12.3 11.81 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 113.994 -1.457 . . . . 1.1799999999999999 108.413 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.448 -0.539 0 CA-C-N 115.104 -0.953 . . . . 1.1499999999999999 110.713 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 112.436 -0.266 . . . . 11.51 112.436 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 68.4 m -144.77 135.67 24.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.734 0.302 . . . . 10.220000000000001 110.993 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 38.9 t80 60.87 101.08 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.948 -0.569 . . . . 10.81 111.142 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 55.8 m -117.83 -48.49 2.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 8.2400000000000002 111.023 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 42.5 tpp -117.72 159.99 22.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.177 -0.465 . . . . 7.21 110.768 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . 0.489 ' ND2' ' H ' ' A' ' 211' ' ' THR . 4.4 p-10 -79.84 -155.57 0.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.347 -0.388 . . . . 5.54 111.195 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.94 -12.39 4.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.197 -0.456 . . . . 2.79 111.738 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.489 ' H ' ' ND2' ' A' ' 209' ' ' ASN . 84.8 m -52.79 -59.7 4.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.567 -0.288 . . . . 1.8200000000000001 111.415 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 86.1 m -52.04 -29.81 22.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.344 -0.389 . . . . 1.8100000000000001 111.895 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 46.4 t -52.09 -37.28 21.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.83 0.348 . . . . 2.0099999999999998 110.656 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -83.48 -32.19 26.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.058 -0.519 . . . . 1.6000000000000001 110.655 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.28 -42.46 80.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.214 -0.448 . . . . 1.55 110.162 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.422 ' O ' ' HG ' ' A' ' 220' ' ' LEU . 51.7 m -57.8 -35.38 70.75 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.411 -0.589 . . . . 1.9199999999999999 109.411 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 89.9 t -76.48 -30.05 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 115.294 -0.866 . . . . 1.21 110.468 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -58.75 -42.93 90.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.573 -0.739 . . . . 0.94999999999999996 110.723 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.41 ' O ' HG21 ' A' ' 223' ' ' VAL . 22.1 t -66.52 -41.41 88.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.737 -0.665 . . . . 1.0700000000000001 111.238 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 216' ' ' SER . 11.1 mt -53.21 -42.51 66.39 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.826 0.346 . . . . 1.05 110.46 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 39.5 t -54.4 -41.49 69.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.846 -0.616 . . . . 1.6100000000000001 109.887 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.4 -36.33 68.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.081 -0.508 . . . . 1.1100000000000001 110.671 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 219' ' ' VAL . 90.3 t -59.33 -54.08 39.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.183 -0.462 . . . . 1.1499999999999999 111.363 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.474 HD13 ' N ' ' A' ' 225' ' ' CYS . 2.7 pp -58.07 -31.52 41.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 121.059 0.456 . . . . 1.1699999999999999 110.232 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . 0.474 ' N ' HD13 ' A' ' 224' ' ' ILE . 54.8 m -66.99 -34.57 78.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.817 -0.629 . . . . 1.8899999999999999 110.288 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 6.2 mp -69.12 -52.47 27.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.661 -0.7 . . . . 1.1899999999999999 111.921 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.515 HG13 ' N ' ' A' ' 228' ' ' ILE . 9.9 pt -53.58 -36.0 27.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 111.945 0.35 . . . . 1.1899999999999999 111.945 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.515 ' N ' HG13 ' A' ' 227' ' ' ILE . 84.2 mt -61.7 -37.33 77.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.162 0.506 . . . . 1.1100000000000001 110.366 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 75.1 t -61.96 -49.05 85.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.45 -0.795 . . . . 1.1399999999999999 111.268 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -71.61 -37.11 70.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.161 0.505 . . . . 0.67000000000000004 110.951 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -62.45 -7.18 4.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.573 -0.74 . . . . 1.0800000000000001 111.801 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 232' ' ' VAL . 78.0 t -117.84 -1.44 9.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.683 0.754 . . . . 1.2 110.283 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.15 -3.69 11.05 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.073 -1.084 . . . . 1.1000000000000001 108.073 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 7.7 mp -120.07 10.57 11.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 113.84 -1.527 . . . . 1.1799999999999999 108.343 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.2 mptt -114.92 3.03 14.45 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.019 -0.992 . . . . 1.1499999999999999 111.472 -178.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.41 ' N ' HG13 ' A' ' 240' ' ' VAL . . . 149.09 54.42 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.637 -0.792 . . . . 1.97 112.469 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -74.62 -44.6 49.82 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.461 -0.37 . . . . 4.2000000000000002 111.187 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 31.1 t -159.31 -65.84 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.507 -0.315 . . . . 5.29 111.379 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 50.8 mtm -127.98 54.24 1.73 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.284 -0.416 . . . . 7.3399999999999999 111.066 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.41 HG13 ' N ' ' A' ' 236' ' ' GLY . 2.7 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.348 -0.834 . . . . 8.1199999999999992 111.313 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 112.546 -0.221 . . . . 11.51 112.546 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 54.7 m 55.98 37.22 28.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 10.220000000000001 110.967 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -73.84 147.55 43.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 10.81 111.017 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 27.3 m 58.56 95.6 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.118 -0.492 . . . . 8.2400000000000002 111.303 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 50.3 tpp -83.87 74.16 10.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.159 -0.473 . . . . 7.21 110.682 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -165.35 -67.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.935 -0.575 . . . . 5.54 110.666 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.57 -10.71 57.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.917 -0.583 . . . . 2.79 110.839 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 98.9 m -55.86 -52.03 65.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.966 -0.561 . . . . 1.8200000000000001 111.26 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.427 ' HA ' HD13 ' A' ' 215' ' ' ILE . 11.4 m -51.97 -28.46 16.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.205 -0.452 . . . . 1.8100000000000001 111.619 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.86 -40.08 60.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.777 0.322 . . . . 2.0099999999999998 110.571 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 49.4 m95 -74.98 -34.72 62.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.446 . . . . 1.6000000000000001 110.053 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 212' ' ' THR . 1.8 mp -57.85 -39.9 73.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 116.038 -0.528 . . . . 1.55 109.833 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 46.2 t -60.57 -35.2 75.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.265 -0.643 . . . . 1.9199999999999999 109.265 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 87.4 t -75.5 -29.94 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 115.244 -0.889 . . . . 1.21 110.01 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.32 -43.98 92.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.533 -0.758 . . . . 0.94999999999999996 110.716 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.436 ' O ' HG21 ' A' ' 223' ' ' VAL . 23.8 t -64.68 -40.04 87.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.611 -0.722 . . . . 1.0700000000000001 111.317 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 9.9 mt -54.6 -41.97 70.56 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.866 0.365 . . . . 1.05 110.496 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.467 ' O ' HG13 ' A' ' 224' ' ' ILE . 51.2 m -54.29 -41.51 68.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.875 -0.602 . . . . 1.6100000000000001 109.892 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.95 -36.26 67.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.941 -0.572 . . . . 1.1100000000000001 110.729 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.436 HG21 ' O ' ' A' ' 219' ' ' VAL . 74.9 t -57.27 -48.11 83.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.853 -0.612 . . . . 1.1499999999999999 112.027 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 221' ' ' SER . 2.2 pp -56.39 -35.83 44.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.958 0.409 . . . . 1.1699999999999999 110.753 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 51.1 t -66.46 -37.47 85.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.058 -0.519 . . . . 1.8899999999999999 110.56 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 9.6 mp -66.17 -52.53 47.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.895 -0.593 . . . . 1.1899999999999999 111.655 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.496 HG13 ' N ' ' A' ' 228' ' ' ILE . 17.6 pt -55.46 -35.81 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.638 -0.256 . . . . 1.1899999999999999 111.655 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.496 ' N ' HG13 ' A' ' 227' ' ' ILE . 82.9 mt -62.24 -39.06 82.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.08 0.467 . . . . 1.1100000000000001 110.271 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 77.7 t -57.09 -49.95 77.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.499 -0.773 . . . . 1.1399999999999999 110.794 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.4 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 3.5 m-90 -72.45 -37.93 68.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.67000000000000004 110.882 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -64.93 -7.16 10.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.642 -0.708 . . . . 1.0800000000000001 111.793 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 232' ' ' VAL . 74.6 t -117.77 -0.95 8.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.836 0.827 . . . . 1.2 110.107 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.04 -4.49 11.03 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.206 -1.035 . . . . 1.1000000000000001 108.206 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 6.8 mp -119.93 10.77 11.62 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 113.843 -1.526 . . . . 1.1799999999999999 108.319 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.1 mptt -114.69 -14.85 12.0 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.061 -0.972 . . . . 1.1499999999999999 111.29 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 150.56 59.02 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.713 -0.756 . . . . 1.97 112.65 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -67.59 -34.62 77.39 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.87 0.367 . . . . 4.2000000000000002 110.465 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' SER . . . . . 0.53 ' HG ' ' HG3' ' A' ' 239' ' ' MET . 41.5 t -155.46 -73.23 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.968 -0.56 . . . . 5.29 110.558 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.53 ' HG3' ' HG ' ' A' ' 238' ' ' SER . 51.1 mtm -136.49 58.11 1.75 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.067 -0.515 . . . . 7.3399999999999999 110.659 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.602 -0.713 . . . . 8.1199999999999992 111.427 -179.913 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 112.48 -0.248 . . . . 11.51 112.48 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 81.1 p -148.06 166.27 28.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.82 0.343 . . . . 10.220000000000001 110.905 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -125.64 20.53 7.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 10.81 110.955 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 73.4 m -123.07 -69.34 0.83 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.178 -0.464 . . . . 8.2400000000000002 111.057 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 54.8 ttm -145.47 -71.86 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 7.21 110.717 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -171.95 -82.87 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.243 -0.435 . . . . 5.54 110.988 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.37 6.68 0.66 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 2.79 110.976 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 88.9 m -64.61 -54.01 38.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.14 -0.482 . . . . 1.8200000000000001 111.225 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 19.5 m -52.14 -23.06 4.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.079 -0.51 . . . . 1.8100000000000001 111.747 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 64.3 t -54.27 -40.54 48.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.689 0.281 . . . . 2.0099999999999998 111.057 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -83.22 -32.19 26.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.304 -0.407 . . . . 1.6000000000000001 110.734 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.03 -37.78 56.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 110.006 -0.368 . . . . 1.55 110.006 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 43.8 t -60.4 -34.98 74.7 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.208 -0.664 . . . . 1.9199999999999999 109.208 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.63 -31.38 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.32 -0.855 . . . . 1.21 110.047 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -58.18 -40.17 80.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.411 -0.813 . . . . 0.94999999999999996 110.674 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 223' ' ' VAL . 20.8 t -66.85 -42.73 89.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.562 -0.745 . . . . 1.0700000000000001 111.244 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.97 -44.16 63.89 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.974 0.416 . . . . 1.05 110.507 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 49.2 m -54.06 -41.21 67.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.714 -0.676 . . . . 1.6100000000000001 110.077 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.33 -36.11 68.77 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.036 -0.529 . . . . 1.1100000000000001 110.636 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 219' ' ' VAL . 95.4 t -58.85 -53.43 47.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.112 -0.495 . . . . 1.1499999999999999 111.496 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.466 HD13 ' N ' ' A' ' 225' ' ' CYS . 2.6 pp -58.25 -31.33 42.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-O 120.991 0.424 . . . . 1.1699999999999999 110.21 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . 0.466 ' N ' HD13 ' A' ' 224' ' ' ILE . 58.2 m -66.96 -34.38 77.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.88 -0.6 . . . . 1.8899999999999999 110.26 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 7.0 mp -70.91 -48.25 54.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.635 -0.712 . . . . 1.1899999999999999 112.198 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.499 HG13 ' N ' ' A' ' 228' ' ' ILE . 12.9 pt -56.95 -36.16 49.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 111.98 0.363 . . . . 1.1899999999999999 111.98 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.499 ' N ' HG13 ' A' ' 227' ' ' ILE . 81.3 mt -61.62 -37.65 78.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.187 0.518 . . . . 1.1100000000000001 110.3 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 79.6 t -58.68 -49.86 81.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.444 -0.798 . . . . 1.1399999999999999 111.036 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.403 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 2.1 m-90 -72.05 -38.92 69.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.07 0.462 . . . . 0.67000000000000004 110.863 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -64.16 -8.08 11.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.705 -0.68 . . . . 1.0800000000000001 111.657 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . 0.484 ' O ' HG11 ' A' ' 232' ' ' VAL . 65.4 t -117.95 -0.44 8.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.9 0.857 . . . . 1.2 110.042 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 237' ' ' TYR . . . -118.22 -2.93 11.08 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.14 -1.059 . . . . 1.1000000000000001 108.14 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 8.0 mp -120.02 8.74 11.06 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 113.917 -1.492 . . . . 1.1799999999999999 108.09 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.2 mptt -115.08 3.15 14.35 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.712 -1.131 . . . . 1.1499999999999999 111.28 -178.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 166.49 47.8 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.634 -0.793 . . . . 1.97 112.669 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.438 ' HB3' ' O ' ' A' ' 233' ' ' ALA . 14.2 p90 -70.97 -2.26 14.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.818 0.342 . . . . 4.2000000000000002 111.095 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 47.9 t -75.57 -12.08 60.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.279 -0.419 . . . . 5.29 110.919 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 55.5 mtt -116.96 37.07 3.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 7.3399999999999999 111.056 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 2.2 m . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.382 -0.818 . . . . 8.1199999999999992 111.298 179.853 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 112.511 -0.236 . . . . 11.51 112.511 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 74.7 p -105.81 88.81 2.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.92 0.391 . . . . 10.220000000000001 110.732 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -88.67 18.04 5.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 10.81 111.114 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 48.4 p 49.64 45.77 24.15 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.957 -0.565 . . . . 8.2400000000000002 111.488 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 56.9 ttp -84.1 145.53 28.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 7.21 110.968 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -118.07 151.85 36.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.447 . . . . 5.54 110.838 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.9 86.61 0.24 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.127 -0.488 . . . . 2.79 111.245 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 59.0 m -97.45 -64.11 1.07 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.072 -0.513 . . . . 1.8200000000000001 111.16 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.429 ' HA ' ' HB ' ' A' ' 215' ' ' ILE . 30.5 m -51.89 -26.66 10.67 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.192 -0.458 . . . . 1.8100000000000001 110.764 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 50.2 t -55.43 -41.65 63.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.8 -0.636 . . . . 2.0099999999999998 110.571 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -83.55 -28.9 28.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.982 -0.554 . . . . 1.6000000000000001 110.871 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.429 ' HB ' ' HA ' ' A' ' 212' ' ' THR . 1.7 mp -55.19 -43.24 69.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.488 -0.324 . . . . 1.55 110.348 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 48.0 t -57.7 -35.96 71.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.387 0.613 . . . . 1.9199999999999999 109.382 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 87.2 t -75.33 -30.1 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 115.19 -0.914 . . . . 1.21 110.16 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -58.38 -39.09 78.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.598 -0.728 . . . . 0.94999999999999996 110.669 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 15.1 t -69.02 -38.1 77.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.518 -0.765 . . . . 1.0700000000000001 111.114 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 13.8 mt -57.69 -47.35 82.57 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 120.851 0.358 . . . . 1.05 110.378 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 50.4 m -54.45 -36.06 63.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.832 -0.622 . . . . 1.6100000000000001 110.061 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.6 -45.47 58.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.974 -0.557 . . . . 1.1100000000000001 110.738 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 69.4 t -57.31 -50.79 75.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.03 -0.532 . . . . 1.1499999999999999 111.509 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.41 HD11 ' N ' ' A' ' 225' ' ' CYS . 2.7 pp -60.69 -31.82 50.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.011 0.434 . . . . 1.1699999999999999 110.244 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . 0.41 ' N ' HD11 ' A' ' 224' ' ' ILE . 35.0 t -66.94 -35.11 79.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.963 -0.562 . . . . 1.8899999999999999 110.147 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 7.4 mp -63.64 -50.5 69.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.575 -0.739 . . . . 1.1899999999999999 111.877 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.499 HG13 ' N ' ' A' ' 228' ' ' ILE . 11.5 pt -59.24 -35.99 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.798 -0.183 . . . . 1.1899999999999999 111.484 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.499 ' N ' HG13 ' A' ' 227' ' ' ILE . 82.7 mt -61.6 -37.79 78.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.194 0.521 . . . . 1.1100000000000001 110.223 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 65.4 t -56.79 -48.85 80.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.453 -0.794 . . . . 1.1399999999999999 110.873 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.415 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 2.4 m-90 -72.36 -40.23 67.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.047 -0.524 . . . . 0.67000000000000004 110.845 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -66.52 -7.27 18.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.7 -0.682 . . . . 1.0800000000000001 111.616 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 232' ' ' VAL . 71.3 t -118.0 -0.06 8.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.931 0.872 . . . . 1.2 109.983 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.29 -3.85 10.97 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.123 -1.065 . . . . 1.1000000000000001 108.123 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.3 mp -119.97 9.92 11.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 113.937 -1.483 . . . . 1.1799999999999999 108.273 178.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.2 mptt -114.99 -56.33 2.39 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.02 -0.991 . . . . 1.1499999999999999 111.832 -178.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -138.18 39.66 1.56 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.035 -0.602 . . . . 1.97 112.891 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -62.35 -18.52 61.66 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.771 0.32 . . . . 4.2000000000000002 111.27 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 41.6 t -82.6 -34.72 27.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.401 -0.363 . . . . 5.29 111.127 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 71.0 mtm -103.1 40.46 1.39 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.279 -0.419 . . . . 7.3399999999999999 111.08 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.025 -0.988 . . . . 8.1199999999999992 111.303 179.862 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 112.563 -0.215 . . . . 11.51 112.563 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 48.7 m -67.98 157.71 34.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.703 0.287 . . . . 10.220000000000001 110.868 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -100.2 118.52 36.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.321 -0.4 . . . . 10.81 111.03 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 24.3 m 59.65 -90.33 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.045 -0.525 . . . . 8.2400000000000002 111.243 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 24.5 mmt 54.23 44.84 28.48 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.318 -0.401 . . . . 7.21 111.365 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -68.02 114.36 6.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.444 -0.344 . . . . 5.54 110.788 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -79.09 -14.74 58.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 2.79 111.32 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 88.8 m -56.05 -52.38 64.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.225 -0.443 . . . . 1.8200000000000001 111.309 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 36.3 m -52.96 -28.3 23.09 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.077 -0.51 . . . . 1.8100000000000001 111.882 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 53.6 t -54.35 -39.5 44.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.871 0.367 . . . . 2.0099999999999998 110.965 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -83.43 -24.99 31.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.07 -0.513 . . . . 1.6000000000000001 110.945 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.52 -42.19 74.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.58 -0.282 . . . . 1.55 110.527 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 80.5 p -57.63 -35.32 70.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.4 0.619 . . . . 1.9199999999999999 109.365 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 92.7 t -75.25 -32.48 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.186 -0.915 . . . . 1.21 110.058 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.33 91.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.44 -0.8 . . . . 0.94999999999999996 110.572 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 24.3 t -63.73 -37.32 79.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.705 -0.679 . . . . 1.0700000000000001 110.732 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 13.0 mt -57.63 -41.44 81.36 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.009 0.433 . . . . 1.05 109.983 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.414 ' O ' HG13 ' A' ' 224' ' ' ILE . 45.7 t -54.14 -37.63 64.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.603 -0.726 . . . . 1.6100000000000001 109.741 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.4 ' O ' HD11 ' A' ' 226' ' ' LEU . . . -72.74 -40.19 66.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.788 -0.642 . . . . 1.1100000000000001 110.347 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 87.8 t -57.24 -53.48 43.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 115.863 -0.608 . . . . 1.1499999999999999 111.7 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.6 pp -56.48 -33.86 39.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.023 0.439 . . . . 1.1699999999999999 110.453 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . 0.42 ' N ' HD12 ' A' ' 224' ' ' ILE . 38.6 t -67.55 -35.01 78.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.972 -0.558 . . . . 1.8899999999999999 110.328 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.4 HD11 ' O ' ' A' ' 222' ' ' ALA . 7.3 mp -68.31 -49.87 57.4 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.555 -0.748 . . . . 1.1899999999999999 112.214 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.51 HG13 ' N ' ' A' ' 228' ' ' ILE . 4.4 pt -53.76 -36.25 29.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.593 0.235 . . . . 1.1899999999999999 111.433 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.51 ' N ' HG13 ' A' ' 227' ' ' ILE . 65.6 mt -66.22 -38.0 80.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.073 0.463 . . . . 1.1100000000000001 110.146 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 225' ' ' CYS . 79.0 t -59.05 -46.05 92.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.646 -0.706 . . . . 1.1399999999999999 110.717 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.448 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 1.9 m-90 -71.95 -41.66 67.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.08 0.467 . . . . 0.67000000000000004 110.2 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -64.79 -8.3 14.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.66 -0.7 . . . . 1.0800000000000001 111.295 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 232' ' ' VAL . 60.7 t -118.31 -1.06 8.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.849 0.833 . . . . 1.2 109.9 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 237' ' ' TYR . . . -118.09 -1.97 11.31 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.272 -1.01 . . . . 1.1000000000000001 108.272 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 8.6 mp -120.46 7.78 10.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 113.907 -1.497 . . . . 1.1799999999999999 107.805 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.3 mptt -115.56 -21.69 9.61 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.852 -1.067 . . . . 1.1499999999999999 112.009 -178.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -148.93 25.4 1.29 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.515 -0.85 . . . . 1.97 113.169 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.529 ' HB3' ' O ' ' A' ' 233' ' ' ALA . 38.2 p90 -67.05 -7.49 23.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.727 0.298 . . . . 4.2000000000000002 110.945 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 52.1 m -84.95 -38.21 19.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 5.29 111.077 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 85.3 mtp -94.13 35.65 1.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 7.3399999999999999 111.133 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.148 -0.929 . . . . 8.1199999999999992 111.325 179.913 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.462 -0.255 . . . . 11.51 112.462 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 50.1 m -113.49 138.59 49.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.829 0.347 . . . . 10.220000000000001 110.917 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -107.86 30.17 6.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.04 -0.527 . . . . 10.81 110.75 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 60.3 p -67.33 -16.41 64.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 8.2400000000000002 111.053 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 65.8 mtm -127.7 84.15 2.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 7.21 110.818 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -60.64 131.24 50.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 5.54 110.689 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -83.94 21.51 1.31 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 2.79 110.933 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.406 HG21 HD12 ' A' ' 215' ' ' ILE . 90.4 m -54.92 -55.52 29.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.396 . . . . 1.8200000000000001 110.764 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.407 ' HA ' ' HB ' ' A' ' 215' ' ' ILE . 17.5 m -53.39 -27.06 22.06 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.935 -0.575 . . . . 1.8100000000000001 111.55 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 47.4 t -59.19 -38.66 75.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.837 0.351 . . . . 2.0099999999999998 110.64 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -82.72 -23.37 34.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.194 -0.457 . . . . 1.6000000000000001 110.42 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.407 ' HB ' ' HA ' ' A' ' 212' ' ' THR . 1.7 mp -65.26 -48.43 83.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.208 -0.451 . . . . 1.55 110.255 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 81.7 p -58.4 -36.07 73.0 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.298 -0.63 . . . . 1.9199999999999999 109.298 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 91.4 t -75.46 -29.89 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.315 -0.857 . . . . 1.21 109.904 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.2 -38.83 90.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.344 -0.843 . . . . 0.94999999999999996 110.609 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.413 ' O ' HG21 ' A' ' 223' ' ' VAL . 21.6 t -69.46 -34.47 62.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.658 -0.701 . . . . 1.0700000000000001 111.415 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 14.0 mt -59.59 -48.71 80.59 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 120.83 0.347 . . . . 1.05 110.692 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.429 ' O ' HG13 ' A' ' 224' ' ' ILE . 94.5 p -54.82 -36.19 64.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.181 0.515 . . . . 1.6100000000000001 109.799 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.0 -37.93 66.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.701 -0.681 . . . . 1.1100000000000001 110.74 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 219' ' ' VAL . 39.6 t -58.99 -52.56 59.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.093 -0.503 . . . . 1.1499999999999999 111.817 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.46 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.7 pp -55.97 -33.35 35.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.909 0.385 . . . . 1.1699999999999999 110.471 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . 0.46 ' N ' HD12 ' A' ' 224' ' ' ILE . 51.2 t -67.4 -34.94 78.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.021 -0.536 . . . . 1.8899999999999999 110.461 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.442 ' HB3' ' HZ3' ' A' ' 230' ' ' TRP . 8.2 mp -70.21 -51.91 27.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.643 -0.708 . . . . 1.1899999999999999 112.105 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 228' ' ' ILE . 4.8 pt -53.59 -36.24 27.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 111.729 0.27 . . . . 1.1899999999999999 111.729 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.5 ' N ' HG13 ' A' ' 227' ' ' ILE . 83.4 mt -65.04 -37.5 80.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.042 0.448 . . . . 1.1100000000000001 110.261 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 78.6 t -60.58 -48.18 89.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.562 -0.745 . . . . 1.1399999999999999 111.075 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.442 ' HZ3' ' HB3' ' A' ' 226' ' ' LEU . 1.8 m-90 -71.85 -40.26 69.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.015 0.436 . . . . 0.67000000000000004 110.634 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.15 -8.16 7.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.808 -0.633 . . . . 1.0800000000000001 111.581 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 232' ' ' VAL . 63.3 t -118.12 -1.82 9.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.794 0.807 . . . . 1.2 110.279 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -117.96 -2.17 11.34 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.263 -1.014 . . . . 1.1000000000000001 108.263 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.8 mp -119.99 8.3 11.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 113.801 -1.545 . . . . 1.1799999999999999 107.956 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -114.81 36.66 3.74 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.688 -1.142 . . . . 1.1499999999999999 111.018 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 163.21 0.67 0.05 OUTLIER Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.752 -0.737 . . . . 1.97 113.075 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.91 -23.15 27.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.787 0.327 . . . . 4.2000000000000002 110.676 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 47.6 t -71.34 -17.37 62.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.017 -0.538 . . . . 5.29 110.964 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 66.8 mtm -111.91 40.41 2.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.391 -0.368 . . . . 7.3399999999999999 111.252 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.17 -0.919 . . . . 8.1199999999999992 111.125 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 112.411 -0.275 . . . . 11.51 112.411 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 59.5 m -150.86 143.62 24.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 10.220000000000001 110.998 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -151.53 13.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 10.81 110.667 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 60.1 m -126.0 94.08 4.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.116 -0.493 . . . . 8.2400000000000002 111.097 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -75.62 -170.17 1.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 7.21 110.865 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -55.19 -74.3 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.245 -0.434 . . . . 5.54 110.98 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.7 6.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 2.79 110.818 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 99.9 m -60.6 -53.9 51.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.442 . . . . 1.8200000000000001 111.009 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.455 ' HA ' HD11 ' A' ' 215' ' ' ILE . 15.4 m -53.2 -23.95 9.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 1.8100000000000001 111.711 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 58.7 t -58.96 -36.88 64.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.916 0.388 . . . . 2.0099999999999998 110.512 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -80.81 -31.05 35.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.035 -0.53 . . . . 1.6000000000000001 110.306 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.455 HD11 ' HA ' ' A' ' 212' ' ' THR . 1.8 mp -58.62 -42.9 86.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.258 -0.428 . . . . 1.55 110.098 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 46.9 t -60.9 -35.58 77.02 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.223 -0.658 . . . . 1.9199999999999999 109.223 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 86.3 t -73.59 -29.41 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.276 -0.875 . . . . 1.21 110.04 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -54.34 -46.69 72.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.514 -0.766 . . . . 0.94999999999999996 110.87 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 19.5 t -65.67 -41.09 89.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.974 -0.557 . . . . 1.0700000000000001 111.058 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 11.8 mt -54.3 -41.18 68.65 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.901 0.382 . . . . 1.05 110.197 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.419 ' O ' HG13 ' A' ' 224' ' ' ILE . 53.9 m -54.15 -41.61 68.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.724 -0.671 . . . . 1.6100000000000001 110.243 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.4 -39.54 67.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.021 -0.536 . . . . 1.1100000000000001 110.691 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 97.6 t -59.2 -53.1 52.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.114 -0.494 . . . . 1.1499999999999999 111.279 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.434 ' HA ' HG12 ' A' ' 227' ' ' ILE . 2.7 pp -58.55 -31.85 44.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.136 0.494 . . . . 1.1699999999999999 110.184 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . 0.432 ' N ' HD11 ' A' ' 224' ' ' ILE . 19.0 m -66.63 -34.42 77.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.576 -0.738 . . . . 1.8899999999999999 110.276 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.45 -53.07 21.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.672 -0.695 . . . . 1.1899999999999999 111.733 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.502 HG13 ' N ' ' A' ' 228' ' ' ILE . 10.9 pt -55.19 -36.2 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.154 0.427 . . . . 1.1899999999999999 112.154 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.502 ' N ' HG13 ' A' ' 227' ' ' ILE . 81.0 mt -62.44 -37.75 79.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.109 0.48 . . . . 1.1100000000000001 110.438 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 67.8 t -59.1 -50.01 81.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.46 -0.791 . . . . 1.1399999999999999 111.063 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 3.1 m-90 -71.77 -36.39 70.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.67000000000000004 110.901 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -65.28 -7.04 11.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.648 -0.705 . . . . 1.0800000000000001 111.604 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . 0.479 ' O ' HG12 ' A' ' 232' ' ' VAL . 71.6 t -117.87 -0.78 8.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.892 0.854 . . . . 1.2 109.953 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.01 -3.56 11.12 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.19 -1.041 . . . . 1.1000000000000001 108.19 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 7.5 mp -120.02 9.03 11.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 113.961 -1.472 . . . . 1.1799999999999999 108.278 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 0.9 OUTLIER -115.14 46.96 1.35 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 114.983 -1.008 . . . . 1.1499999999999999 111.656 -178.131 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 145.97 -1.13 0.9 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.497 -0.858 . . . . 1.97 112.959 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.95 -23.57 14.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.901 0.382 . . . . 4.2000000000000002 110.864 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 43.3 t -68.67 -7.47 33.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 5.29 111.071 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 48.8 mtm -124.64 35.83 4.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.428 -0.351 . . . . 7.3399999999999999 111.198 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.504 -0.76 . . . . 8.1199999999999992 111.222 179.98 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.444 -0.262 . . . . 11.51 112.444 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 47.2 t 61.12 -84.28 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.738 0.304 . . . . 10.220000000000001 111.179 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -86.05 93.72 9.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.881 0.372 . . . . 10.81 110.818 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 87.7 m -154.67 -66.59 0.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 8.2400000000000002 111.035 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 91.8 mmm 64.18 118.4 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.145 -0.48 . . . . 7.21 111.317 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -120.16 112.95 19.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 5.54 110.937 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -176.21 7.5 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.014 -0.539 . . . . 2.79 110.63 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 60.4 m -53.28 -56.2 18.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 1.8200000000000001 111.646 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 14.9 m -52.19 -26.3 11.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 1.8100000000000001 112.036 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 59.0 t -61.05 -40.09 84.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.822 0.344 . . . . 2.0099999999999998 110.841 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 48.7 m95 -78.8 -28.0 44.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.176 -0.466 . . . . 1.6000000000000001 110.058 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.84 -41.12 84.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.028 -0.533 . . . . 1.55 110.279 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 49.4 m -60.11 -35.7 75.82 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.27 -0.641 . . . . 1.9199999999999999 109.27 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 98.4 t -74.11 -29.9 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 115.188 -0.914 . . . . 1.21 110.196 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -55.7 -41.89 74.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.568 -0.742 . . . . 0.94999999999999996 110.842 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 24.9 t -67.46 -41.98 86.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.719 -0.673 . . . . 1.0700000000000001 111.214 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 13.6 mt -52.51 -44.38 65.66 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.965 0.412 . . . . 1.05 110.428 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.406 ' O ' HG13 ' A' ' 224' ' ' ILE . 56.6 m -54.17 -41.1 68.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.766 -0.652 . . . . 1.6100000000000001 110.155 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.09 -36.9 69.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 1.1100000000000001 110.847 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 76.7 t -60.94 -53.07 54.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-N 116.151 -0.477 . . . . 1.1499999999999999 111.358 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.415 HD11 ' N ' ' A' ' 225' ' ' CYS . 2.7 pp -59.74 -31.8 48.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.163 0.506 . . . . 1.1699999999999999 110.085 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . 0.426 ' HA ' HD11 ' A' ' 228' ' ' ILE . 33.6 m -66.55 -34.83 78.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.708 -0.678 . . . . 1.8899999999999999 110.273 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.1 mp -62.12 -55.23 30.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.688 -0.687 . . . . 1.1899999999999999 111.687 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.505 HG13 ' N ' ' A' ' 228' ' ' ILE . 16.2 pt -55.67 -35.78 40.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.486 -0.325 . . . . 1.1899999999999999 111.806 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.505 ' N ' HG13 ' A' ' 227' ' ' ILE . 83.8 mt -62.14 -39.67 84.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.149 0.5 . . . . 1.1100000000000001 110.248 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 79.2 t -56.41 -48.25 80.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.485 -0.779 . . . . 1.1399999999999999 110.663 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.422 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 3.0 m-90 -72.43 -39.79 67.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.003 -0.544 . . . . 0.67000000000000004 110.861 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -67.14 -7.21 21.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.614 -0.721 . . . . 1.0800000000000001 111.493 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . 0.479 ' O ' HG12 ' A' ' 232' ' ' VAL . 62.8 t -117.96 -0.06 8.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.836 0.827 . . . . 1.2 109.95 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.18 -4.31 10.99 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.097 -1.075 . . . . 1.1000000000000001 108.097 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.1 mp -119.94 9.45 11.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.873 -1.512 . . . . 1.1799999999999999 108.342 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 0.8 OUTLIER -114.76 -1.59 13.21 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.884 -1.053 . . . . 1.1499999999999999 111.039 -178.6 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 134.77 58.07 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.875 -0.679 . . . . 1.97 112.291 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -66.97 -4.2 9.01 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.339 -0.43 . . . . 4.2000000000000002 111.2 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 53.9 m -79.95 -33.38 39.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.306 -0.407 . . . . 5.29 111.37 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 55.5 mtm -125.53 42.58 3.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.407 -0.36 . . . . 7.3399999999999999 111.567 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.105 -0.95 . . . . 8.1199999999999992 111.165 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.576 -0.21 . . . . 11.51 112.576 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 53.9 m -140.77 130.9 24.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.762 0.315 . . . . 10.220000000000001 110.903 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -136.12 129.04 31.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 10.81 110.959 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.587 HG22 ' HG2' ' A' ' 208' ' ' MET . 27.0 m -101.14 141.05 34.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.073 -0.512 . . . . 8.2400000000000002 110.901 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.587 ' HG2' HG22 ' A' ' 207' ' ' THR . 25.3 mmt 63.07 -82.21 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.166 -0.47 . . . . 7.21 111.195 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -60.95 143.12 55.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.92 0.391 . . . . 5.54 110.965 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -167.28 12.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.995 -0.548 . . . . 2.79 110.553 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 91.4 m -57.77 -53.11 61.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.046 -0.524 . . . . 1.8200000000000001 111.276 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 12.9 m -53.39 -27.23 22.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 1.8100000000000001 111.805 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.18 -34.38 56.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.87 0.367 . . . . 2.0099999999999998 110.533 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -82.03 -29.6 31.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.07 -0.514 . . . . 1.6000000000000001 110.111 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.37 -45.24 99.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.058 -0.519 . . . . 1.55 110.021 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.411 ' O ' ' HG ' ' A' ' 220' ' ' LEU . 78.3 p -59.04 -34.93 72.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.18 -0.674 . . . . 1.9199999999999999 109.18 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 87.4 t -74.9 -29.65 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.293 -0.867 . . . . 1.21 110.221 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.0 -45.38 90.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.463 -0.79 . . . . 0.94999999999999996 110.814 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 223' ' ' VAL . 19.5 t -64.35 -41.01 91.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.672 -0.695 . . . . 1.0700000000000001 111.416 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 216' ' ' SER . 11.3 mt -52.71 -43.31 65.56 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.819 0.342 . . . . 1.05 110.599 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.417 ' O ' HG13 ' A' ' 224' ' ' ILE . 55.5 m -54.42 -41.35 69.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.947 -0.57 . . . . 1.6100000000000001 110.133 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.66 -38.01 67.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.036 -0.529 . . . . 1.1100000000000001 110.903 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 219' ' ' VAL . 92.4 t -61.2 -51.68 70.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 115.996 -0.547 . . . . 1.1499999999999999 111.843 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.498 ' HA ' HG12 ' A' ' 227' ' ' ILE . 2.6 pp -56.11 -32.57 34.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.92 0.39 . . . . 1.1699999999999999 110.416 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . 0.434 ' N ' HD11 ' A' ' 224' ' ' ILE . 53.0 t -67.12 -35.41 79.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.509 . . . . 1.8899999999999999 110.297 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 8.3 mp -71.41 -49.05 45.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.731 -0.668 . . . . 1.1899999999999999 111.8 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.52 HG13 ' N ' ' A' ' 228' ' ' ILE . 12.5 pt -57.31 -36.1 51.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.668 -0.242 . . . . 1.1899999999999999 111.572 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.52 ' N ' HG13 ' A' ' 227' ' ' ILE . 81.5 mt -63.14 -37.61 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.147 0.498 . . . . 1.1100000000000001 110.165 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 225' ' ' CYS . 74.9 t -60.82 -47.99 90.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.524 -0.762 . . . . 1.1399999999999999 110.949 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.424 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 2.2 m-90 -72.22 -40.94 67.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.049 0.452 . . . . 0.67000000000000004 110.871 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -64.15 -7.73 9.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.672 -0.695 . . . . 1.0800000000000001 111.562 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . 0.465 ' O ' HG12 ' A' ' 232' ' ' VAL . 68.3 t -118.02 -0.71 8.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.769 0.795 . . . . 1.2 110.133 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.25 -3.99 10.98 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.127 -1.064 . . . . 1.1000000000000001 108.127 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.4 mp -119.79 8.95 11.23 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 113.894 -1.503 . . . . 1.1799999999999999 108.119 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.1 mptt -115.05 -7.12 12.52 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.911 -1.041 . . . . 1.1499999999999999 111.187 -178.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 165.65 -12.3 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.771 -0.728 . . . . 1.97 112.677 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 32.9 p90 34.21 35.3 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.614 0.598 . . . . 4.2000000000000002 112.614 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 61.5 m -91.6 -31.49 15.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.374 -0.376 . . . . 5.29 111.125 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 62.7 mtt -109.34 37.12 2.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 7.3399999999999999 110.974 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.463 -0.779 . . . . 8.1199999999999992 111.198 179.963 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 112.571 -0.212 . . . . 11.51 112.571 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.459 ' HG ' HG23 ' A' ' 207' ' ' THR . 43.6 t -132.19 -58.98 0.94 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.733 0.301 . . . . 10.220000000000001 110.951 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 55.02 81.37 0.11 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.144 -0.48 . . . . 10.81 111.107 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.459 HG23 ' HG ' ' A' ' 205' ' ' SER . 73.5 p -108.63 47.9 0.89 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.081 -0.508 . . . . 8.2400000000000002 111.2 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 10.8 tmm? -155.62 -51.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 7.21 110.713 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -88.23 1.17 55.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.485 . . . . 5.54 111.005 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -62.83 -19.84 64.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 2.79 111.241 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 92.4 m -54.47 -56.07 22.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.32 -0.4 . . . . 1.8200000000000001 110.957 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 13.5 m -53.66 -25.14 16.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.002 -0.544 . . . . 1.8100000000000001 111.848 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 48.4 t -57.72 -37.62 60.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.799 0.333 . . . . 2.0099999999999998 110.76 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 62.2 m95 -81.84 -31.79 31.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.203 -0.453 . . . . 1.6000000000000001 110.355 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.0 -40.21 62.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 116.263 -0.426 . . . . 1.55 110.02 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 61.9 m -58.42 -35.16 71.65 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.377 -0.601 . . . . 1.9199999999999999 109.377 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 92.9 t -75.07 -29.89 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.481 -0.781 . . . . 1.21 110.151 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.14 -40.95 97.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.526 -0.761 . . . . 0.94999999999999996 110.788 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 21.1 t -66.08 -37.06 78.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.66 -0.7 . . . . 1.0700000000000001 111.407 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 12.0 mt -55.92 -44.7 78.55 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 120.917 0.389 . . . . 1.05 110.458 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.47 ' O ' HG13 ' A' ' 224' ' ' ILE . 47.9 t -54.3 -39.41 66.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.794 -0.639 . . . . 1.6100000000000001 110.219 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.04 -39.31 66.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.978 -0.555 . . . . 1.1100000000000001 110.851 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 62.0 t -57.44 -50.45 76.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 115.948 -0.569 . . . . 1.1499999999999999 112.018 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 221' ' ' SER . 2.6 pp -56.56 -33.26 39.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.93 0.395 . . . . 1.1699999999999999 110.667 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . 0.41 ' N ' HD13 ' A' ' 224' ' ' ILE . 51.5 t -67.36 -35.15 78.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 1.8899999999999999 110.566 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 8.8 mp -67.1 -50.29 62.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.764 -0.653 . . . . 1.1899999999999999 111.932 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.53 HG13 ' N ' ' A' ' 228' ' ' ILE . 10.2 pt -55.82 -36.22 42.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 111.593 0.22 . . . . 1.1899999999999999 111.593 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.53 ' N ' HG13 ' A' ' 227' ' ' ILE . 75.2 mt -62.55 -37.97 80.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.052 0.453 . . . . 1.1100000000000001 110.166 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 75.4 t -58.06 -48.05 85.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.492 -0.776 . . . . 1.1399999999999999 110.673 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.428 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 2.5 m-90 -71.95 -38.85 69.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.082 -0.508 . . . . 0.67000000000000004 110.522 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.6 -7.37 14.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.719 -0.673 . . . . 1.0800000000000001 111.472 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 232' ' ' VAL . 68.0 t -117.57 -1.28 9.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.75 0.786 . . . . 1.2 109.938 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 237' ' ' TYR . . . -118.28 -3.62 10.99 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.087 -1.079 . . . . 1.1000000000000001 108.087 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.0 mp -120.17 12.3 11.81 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 113.994 -1.457 . . . . 1.1799999999999999 108.413 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.06 50.26 0.94 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.104 -0.953 . . . . 1.1499999999999999 110.713 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 136.94 14.23 0.88 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.606 -0.724 . . . . 1.97 112.266 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 233' ' ' ALA . 39.1 m-85 -127.66 -7.12 5.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.767 0.318 . . . . 4.2000000000000002 111.066 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 11.2 t -102.43 -43.41 5.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 5.29 110.891 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 77.3 mtp -86.66 32.38 0.66 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.901 -0.59 . . . . 7.3399999999999999 111.325 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.567 -0.73 . . . . 8.1199999999999992 111.396 -179.986 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.478 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.7 pp . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 121.059 0.456 . . . . 0.51000000000000001 110.232 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.478 ' N ' HD12 ' A' ' 224' ' ' ILE . 54.8 m -66.99 -34.57 78.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.817 -0.629 . . . . 1.3600000000000001 110.288 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 6.2 mp -69.12 -52.47 27.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.661 -0.7 . . . . 0.51000000000000001 111.921 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.527 HG13 ' N ' ' A' ' 228' ' ' ILE . 9.9 pt -53.58 -36.0 27.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 111.945 0.35 . . . . 0.46000000000000002 111.945 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.527 ' N ' HG13 ' A' ' 227' ' ' ILE . 84.2 mt -61.7 -37.33 77.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.162 0.506 . . . . 0.35999999999999999 110.366 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 75.1 t -61.96 -49.05 85.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.45 -0.795 . . . . 0.29999999999999999 111.268 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -71.61 -37.11 70.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.161 0.505 . . . . 0.58999999999999997 110.951 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -62.45 -7.18 4.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.573 -0.74 . . . . 0.28999999999999998 111.801 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' VAL . . . . . 0.519 ' O ' HG12 ' A' ' 232' ' ' VAL . 78.0 t -117.84 -1.44 9.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.683 0.754 . . . . 0.51000000000000001 110.283 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.15 -3.69 11.05 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.073 -1.084 . . . . 0.52000000000000002 108.073 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 7.7 mp -120.07 10.57 11.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 113.84 -1.527 . . . . 0.59999999999999998 108.343 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.2 mptt . . . . . 0 N--CA 1.452 -0.353 0 CA-C-N 115.019 -0.992 . . . . 0.81999999999999995 111.472 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 CA--C 1.524 -0.041 0 CA-C-O 120.958 0.409 . . . . 0.51000000000000001 110.753 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 51.1 t -66.46 -37.47 85.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.058 -0.519 . . . . 1.3600000000000001 110.56 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 9.6 mp -66.17 -52.53 47.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.895 -0.593 . . . . 0.51000000000000001 111.655 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.514 HG13 ' N ' ' A' ' 228' ' ' ILE . 17.6 pt -55.46 -35.81 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.638 -0.256 . . . . 0.46000000000000002 111.655 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.514 ' N ' HG13 ' A' ' 227' ' ' ILE . 82.9 mt -62.24 -39.06 82.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.08 0.467 . . . . 0.35999999999999999 110.271 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 77.7 t -57.09 -49.95 77.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.499 -0.773 . . . . 0.29999999999999999 110.794 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -72.45 -37.93 68.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.58999999999999997 110.882 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -64.93 -7.16 10.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.642 -0.708 . . . . 0.28999999999999998 111.793 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 232' ' ' VAL . 74.6 t -117.77 -0.95 8.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.836 0.827 . . . . 0.51000000000000001 110.107 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.04 -4.49 11.03 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.206 -1.035 . . . . 0.52000000000000002 108.206 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 6.8 mp -119.93 10.77 11.62 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 113.843 -1.526 . . . . 0.59999999999999998 108.319 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.1 mptt . . . . . 0 N--CA 1.45 -0.435 0 CA-C-N 115.061 -0.972 . . . . 0.81999999999999995 111.29 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.469 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.6 pp . . . . . 0 CA--C 1.523 -0.091 0 CA-C-O 120.991 0.424 . . . . 0.51000000000000001 110.21 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.469 ' N ' HD12 ' A' ' 224' ' ' ILE . 58.2 m -66.96 -34.38 77.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.88 -0.6 . . . . 1.3600000000000001 110.26 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 7.0 mp -70.91 -48.25 54.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.635 -0.712 . . . . 0.51000000000000001 112.198 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.518 HG13 ' N ' ' A' ' 228' ' ' ILE . 12.9 pt -56.95 -36.16 49.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 111.98 0.363 . . . . 0.46000000000000002 111.98 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.518 ' N ' HG13 ' A' ' 227' ' ' ILE . 81.3 mt -61.62 -37.65 78.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.187 0.518 . . . . 0.35999999999999999 110.3 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 79.6 t -58.68 -49.86 81.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.444 -0.798 . . . . 0.29999999999999999 111.036 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.403 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 2.1 m-90 -72.05 -38.92 69.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.07 0.462 . . . . 0.58999999999999997 110.863 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -64.16 -8.08 11.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.705 -0.68 . . . . 0.28999999999999998 111.657 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' VAL . . . . . 0.512 ' O ' HG12 ' A' ' 232' ' ' VAL . 65.4 t -117.95 -0.44 8.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.9 0.857 . . . . 0.51000000000000001 110.042 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.22 -2.93 11.08 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.14 -1.059 . . . . 0.52000000000000002 108.14 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 8.0 mp -120.02 8.74 11.06 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 113.917 -1.492 . . . . 0.59999999999999998 108.09 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.2 mptt . . . . . 0 N--CA 1.451 -0.408 0 CA-C-N 114.712 -1.131 . . . . 0.81999999999999995 111.28 -178.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.418 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.7 pp . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 121.011 0.434 . . . . 0.51000000000000001 110.244 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.418 ' N ' HD12 ' A' ' 224' ' ' ILE . 35.0 t -66.94 -35.11 79.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.963 -0.562 . . . . 1.3600000000000001 110.147 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 7.4 mp -63.64 -50.5 69.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.575 -0.739 . . . . 0.51000000000000001 111.877 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.514 HG13 ' N ' ' A' ' 228' ' ' ILE . 11.5 pt -59.24 -35.99 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.798 -0.183 . . . . 0.46000000000000002 111.484 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.514 ' N ' HG13 ' A' ' 227' ' ' ILE . 82.7 mt -61.6 -37.79 78.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.194 0.521 . . . . 0.35999999999999999 110.223 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 65.4 t -56.79 -48.85 80.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.453 -0.794 . . . . 0.29999999999999999 110.873 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.412 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 2.4 m-90 -72.36 -40.23 67.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.047 -0.524 . . . . 0.58999999999999997 110.845 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -66.52 -7.27 18.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.7 -0.682 . . . . 0.28999999999999998 111.616 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' VAL . . . . . 0.521 ' O ' HG12 ' A' ' 232' ' ' VAL . 71.3 t -118.0 -0.06 8.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.931 0.872 . . . . 0.51000000000000001 109.983 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.29 -3.85 10.97 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.123 -1.065 . . . . 0.52000000000000002 108.123 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.3 mp -119.97 9.92 11.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 113.937 -1.483 . . . . 0.59999999999999998 108.273 178.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.2 mptt . . . . . 0 N--CA 1.451 -0.413 0 CA-C-N 115.02 -0.991 . . . . 0.81999999999999995 111.832 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.438 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.6 pp . . . . . 0 C--O 1.23 0.055 0 CA-C-O 121.023 0.439 . . . . 0.51000000000000001 110.453 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.438 ' N ' HD12 ' A' ' 224' ' ' ILE . 38.6 t -67.55 -35.01 78.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.972 -0.558 . . . . 1.3600000000000001 110.328 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.31 -49.87 57.4 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.555 -0.748 . . . . 0.51000000000000001 112.214 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.52 HG13 ' N ' ' A' ' 228' ' ' ILE . 4.4 pt -53.76 -36.25 29.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.593 0.235 . . . . 0.46000000000000002 111.433 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.52 ' N ' HG13 ' A' ' 227' ' ' ILE . 65.6 mt -66.22 -38.0 80.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.073 0.463 . . . . 0.35999999999999999 110.146 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 225' ' ' CYS . 79.0 t -59.05 -46.05 92.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.646 -0.706 . . . . 0.29999999999999999 110.717 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.446 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 1.9 m-90 -71.95 -41.66 67.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.08 0.467 . . . . 0.58999999999999997 110.2 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -64.79 -8.3 14.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.66 -0.7 . . . . 0.28999999999999998 111.295 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' VAL . . . . . 0.499 ' O ' HG12 ' A' ' 232' ' ' VAL . 60.7 t -118.31 -1.06 8.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.849 0.833 . . . . 0.51000000000000001 109.9 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.09 -1.97 11.31 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.272 -1.01 . . . . 0.52000000000000002 108.272 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 8.6 mp -120.46 7.78 10.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 113.907 -1.497 . . . . 0.59999999999999998 107.805 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.3 mptt . . . . . 0 N--CA 1.45 -0.47 0 CA-C-N 114.852 -1.067 . . . . 0.81999999999999995 112.009 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.7 pp . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.909 0.385 . . . . 0.51000000000000001 110.471 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.475 ' N ' HD12 ' A' ' 224' ' ' ILE . 51.2 t -67.4 -34.94 78.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.021 -0.536 . . . . 1.3600000000000001 110.461 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.451 ' HB3' ' HZ3' ' A' ' 230' ' ' TRP . 8.2 mp -70.21 -51.91 27.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.643 -0.708 . . . . 0.51000000000000001 112.105 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.512 HG13 ' N ' ' A' ' 228' ' ' ILE . 4.8 pt -53.59 -36.24 27.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 111.729 0.27 . . . . 0.46000000000000002 111.729 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.512 ' N ' HG13 ' A' ' 227' ' ' ILE . 83.4 mt -65.04 -37.5 80.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.042 0.448 . . . . 0.35999999999999999 110.261 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 225' ' ' CYS . 78.6 t -60.58 -48.18 89.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.562 -0.745 . . . . 0.29999999999999999 111.075 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.451 ' HZ3' ' HB3' ' A' ' 226' ' ' LEU . 1.8 m-90 -71.85 -40.26 69.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.015 0.436 . . . . 0.58999999999999997 110.634 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.15 -8.16 7.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.808 -0.633 . . . . 0.28999999999999998 111.581 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' VAL . . . . . 0.504 ' O ' HG12 ' A' ' 232' ' ' VAL . 63.3 t -118.12 -1.82 9.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.794 0.807 . . . . 0.51000000000000001 110.279 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -117.96 -2.17 11.34 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.263 -1.014 . . . . 0.52000000000000002 108.263 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.8 mp -119.99 8.3 11.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 113.801 -1.545 . . . . 0.59999999999999998 107.956 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 1.3 mptt . . . . . 0 N--CA 1.452 -0.355 0 CA-C-N 114.688 -1.142 . . . . 0.81999999999999995 111.018 -178.529 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.429 ' HA ' HG12 ' A' ' 227' ' ' ILE . 2.7 pp . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 121.136 0.494 . . . . 0.51000000000000001 110.184 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.428 ' N ' HD12 ' A' ' 224' ' ' ILE . 19.0 m -66.63 -34.42 77.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.576 -0.738 . . . . 1.3600000000000001 110.276 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.45 -53.07 21.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.672 -0.695 . . . . 0.51000000000000001 111.733 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.518 HG13 ' N ' ' A' ' 228' ' ' ILE . 10.9 pt -55.19 -36.2 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.154 0.427 . . . . 0.46000000000000002 112.154 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.518 ' N ' HG13 ' A' ' 227' ' ' ILE . 81.0 mt -62.44 -37.75 79.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.109 0.48 . . . . 0.35999999999999999 110.438 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 67.8 t -59.1 -50.01 81.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.46 -0.791 . . . . 0.29999999999999999 111.063 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 3.1 m-90 -71.77 -36.39 70.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.58999999999999997 110.901 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -65.28 -7.04 11.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.648 -0.705 . . . . 0.28999999999999998 111.604 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 232' ' ' VAL . 71.6 t -117.87 -0.78 8.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.892 0.854 . . . . 0.51000000000000001 109.953 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.01 -3.56 11.12 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.19 -1.041 . . . . 0.52000000000000002 108.19 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 7.5 mp -120.02 9.03 11.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 113.961 -1.472 . . . . 0.59999999999999998 108.278 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.452 -0.362 0 CA-C-N 114.983 -1.008 . . . . 0.81999999999999995 111.656 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.7 pp . . . . . 0 CA--C 1.521 -0.152 0 CA-C-O 121.163 0.506 . . . . 0.51000000000000001 110.085 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.44 ' HA ' HD12 ' A' ' 228' ' ' ILE . 33.6 m -66.55 -34.83 78.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.708 -0.678 . . . . 1.3600000000000001 110.273 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.1 mp -62.12 -55.23 30.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.688 -0.687 . . . . 0.51000000000000001 111.687 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.521 HG13 ' N ' ' A' ' 228' ' ' ILE . 16.2 pt -55.67 -35.78 40.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.486 -0.325 . . . . 0.46000000000000002 111.806 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.521 ' N ' HG13 ' A' ' 227' ' ' ILE . 83.8 mt -62.14 -39.67 84.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.149 0.5 . . . . 0.35999999999999999 110.248 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 79.2 t -56.41 -48.25 80.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.485 -0.779 . . . . 0.29999999999999999 110.663 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.418 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 3.0 m-90 -72.43 -39.79 67.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.003 -0.544 . . . . 0.58999999999999997 110.861 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -67.14 -7.21 21.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.614 -0.721 . . . . 0.28999999999999998 111.493 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' VAL . . . . . 0.521 ' O ' HG12 ' A' ' 232' ' ' VAL . 62.8 t -117.96 -0.06 8.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.836 0.827 . . . . 0.51000000000000001 109.95 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.18 -4.31 10.99 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.097 -1.075 . . . . 0.52000000000000002 108.097 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.1 mp -119.94 9.45 11.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.873 -1.512 . . . . 0.59999999999999998 108.342 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.452 -0.342 0 CA-C-N 114.884 -1.053 . . . . 0.81999999999999995 111.039 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.498 ' HA ' HG12 ' A' ' 227' ' ' ILE . 2.6 pp . . . . . 0 N--CA 1.458 -0.073 0 CA-C-O 120.92 0.39 . . . . 0.51000000000000001 110.416 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.448 ' N ' HD12 ' A' ' 224' ' ' ILE . 53.0 t -67.12 -35.41 79.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.509 . . . . 1.3600000000000001 110.297 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 8.3 mp -71.41 -49.05 45.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.731 -0.668 . . . . 0.51000000000000001 111.8 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.535 HG13 ' N ' ' A' ' 228' ' ' ILE . 12.5 pt -57.31 -36.1 51.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.668 -0.242 . . . . 0.46000000000000002 111.572 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.535 ' N ' HG13 ' A' ' 227' ' ' ILE . 81.5 mt -63.14 -37.61 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.147 0.498 . . . . 0.35999999999999999 110.165 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 225' ' ' CYS . 74.9 t -60.82 -47.99 90.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.524 -0.762 . . . . 0.29999999999999999 110.949 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.42 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 2.2 m-90 -72.22 -40.94 67.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.049 0.452 . . . . 0.58999999999999997 110.871 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -64.15 -7.73 9.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.672 -0.695 . . . . 0.28999999999999998 111.562 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 232' ' ' VAL . 68.3 t -118.02 -0.71 8.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.769 0.795 . . . . 0.51000000000000001 110.133 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.25 -3.99 10.98 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.127 -1.064 . . . . 0.52000000000000002 108.127 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.4 mp -119.79 8.95 11.23 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 113.894 -1.503 . . . . 0.59999999999999998 108.119 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.1 mptt . . . . . 0 N--CA 1.45 -0.426 0 CA-C-N 114.911 -1.041 . . . . 0.81999999999999995 111.187 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.433 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.6 pp . . . . . 0 CA--C 1.524 -0.041 0 CA-C-O 120.93 0.395 . . . . 0.51000000000000001 110.667 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.433 ' N ' HD12 ' A' ' 224' ' ' ILE . 51.5 t -67.36 -35.15 78.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 1.3600000000000001 110.566 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 8.8 mp -67.1 -50.29 62.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.764 -0.653 . . . . 0.51000000000000001 111.932 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.546 HG13 ' N ' ' A' ' 228' ' ' ILE . 10.2 pt -55.82 -36.22 42.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 111.593 0.22 . . . . 0.46000000000000002 111.593 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.546 ' N ' HG13 ' A' ' 227' ' ' ILE . 75.2 mt -62.55 -37.97 80.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.052 0.453 . . . . 0.35999999999999999 110.166 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 75.4 t -58.06 -48.05 85.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.492 -0.776 . . . . 0.29999999999999999 110.673 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.428 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 2.5 m-90 -71.95 -38.85 69.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.082 -0.508 . . . . 0.58999999999999997 110.522 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.6 -7.37 14.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.719 -0.673 . . . . 0.28999999999999998 111.472 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 232' ' ' VAL . 68.0 t -117.57 -1.28 9.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.75 0.786 . . . . 0.51000000000000001 109.938 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.28 -3.62 10.99 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.087 -1.079 . . . . 0.52000000000000002 108.087 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.0 mp -120.17 12.3 11.81 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 113.994 -1.457 . . . . 0.59999999999999998 108.413 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.448 -0.539 0 CA-C-N 115.104 -0.953 . . . . 0.81999999999999995 110.713 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 112.436 -0.266 . . . . 11.27 112.436 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 68.4 m -144.77 135.67 24.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.734 0.302 . . . . 10.029999999999999 110.993 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 38.9 t80 60.87 101.08 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.948 -0.569 . . . . 10.18 111.142 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 55.8 m -117.83 -48.49 2.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 7.9400000000000004 111.023 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 42.5 tpp -117.72 159.99 22.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.177 -0.465 . . . . 6.7400000000000002 110.768 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -79.84 -155.57 0.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.347 -0.388 . . . . 4.9100000000000001 111.195 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.94 -12.39 4.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.197 -0.456 . . . . 2.79 111.738 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 84.8 m -52.79 -59.7 4.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.567 -0.288 . . . . 1.6200000000000001 111.415 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 86.1 m -52.04 -29.81 22.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.344 -0.389 . . . . 1.3 111.895 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 46.4 t -52.09 -37.28 21.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.83 0.348 . . . . 1.4099999999999999 110.656 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -83.48 -32.19 26.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.058 -0.519 . . . . 1.45 110.655 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.28 -42.46 80.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.214 -0.448 . . . . 0.91000000000000003 110.162 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.425 ' O ' ' HG ' ' A' ' 220' ' ' LEU . 51.7 m -57.8 -35.38 70.75 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.411 -0.589 . . . . 1.3500000000000001 109.411 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 89.9 t -76.48 -30.05 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 115.294 -0.866 . . . . 0.47999999999999998 110.468 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -58.75 -42.93 90.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.573 -0.739 . . . . 0.27000000000000002 110.723 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 223' ' ' VAL . 22.1 t -66.52 -41.41 88.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.737 -0.665 . . . . 0.27000000000000002 111.238 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 216' ' ' SER . 11.1 mt -53.21 -42.51 66.39 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.27000000000000002 110.46 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 39.5 t -54.4 -41.49 69.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.846 -0.616 . . . . 1.1399999999999999 109.887 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.4 -36.33 68.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.081 -0.508 . . . . 0.38 110.671 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 219' ' ' VAL . 90.3 t -59.33 -54.08 39.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.183 -0.462 . . . . 0.48999999999999999 111.363 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.478 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.7 pp -58.07 -31.52 41.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 121.059 0.456 . . . . 0.51000000000000001 110.232 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.478 ' N ' HD12 ' A' ' 224' ' ' ILE . 54.8 m -66.99 -34.57 78.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.817 -0.629 . . . . 1.3600000000000001 110.288 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 6.2 mp -69.12 -52.47 27.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.661 -0.7 . . . . 0.51000000000000001 111.921 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.527 HG13 ' N ' ' A' ' 228' ' ' ILE . 9.9 pt -53.58 -36.0 27.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 111.945 0.35 . . . . 0.46000000000000002 111.945 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.527 ' N ' HG13 ' A' ' 227' ' ' ILE . 84.2 mt -61.7 -37.33 77.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.162 0.506 . . . . 0.35999999999999999 110.366 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 75.1 t -61.96 -49.05 85.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.45 -0.795 . . . . 0.29999999999999999 111.268 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -71.61 -37.11 70.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.161 0.505 . . . . 0.58999999999999997 110.951 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -62.45 -7.18 4.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.573 -0.74 . . . . 0.28999999999999998 111.801 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.519 ' O ' HG12 ' A' ' 232' ' ' VAL . 78.0 t -117.84 -1.44 9.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.683 0.754 . . . . 0.51000000000000001 110.283 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.15 -3.69 11.05 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.073 -1.084 . . . . 0.52000000000000002 108.073 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 7.7 mp -120.07 10.57 11.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 113.84 -1.527 . . . . 0.59999999999999998 108.343 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.2 mptt -114.92 3.03 14.45 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.019 -0.992 . . . . 0.81999999999999995 111.472 -178.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.451 ' N ' HG11 ' A' ' 240' ' ' VAL . . . 149.09 54.42 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.637 -0.792 . . . . 1.97 112.469 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -74.62 -44.6 49.82 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.461 -0.37 . . . . 4.0 111.187 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 31.1 t -159.31 -65.84 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.507 -0.315 . . . . 5.29 111.379 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 50.8 mtm -127.98 54.24 1.73 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.284 -0.416 . . . . 6.96 111.066 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.451 HG11 ' N ' ' A' ' 236' ' ' GLY . 2.7 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.348 -0.834 . . . . 8.1199999999999992 111.313 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 112.546 -0.221 . . . . 11.27 112.546 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 54.7 m 55.98 37.22 28.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 10.029999999999999 110.967 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -73.84 147.55 43.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 10.18 111.017 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 27.3 m 58.56 95.6 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.118 -0.492 . . . . 7.9400000000000004 111.303 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 50.3 tpp -83.87 74.16 10.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.159 -0.473 . . . . 6.7400000000000002 110.682 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -165.35 -67.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.935 -0.575 . . . . 4.9100000000000001 110.666 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.57 -10.71 57.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.917 -0.583 . . . . 2.79 110.839 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 98.9 m -55.86 -52.03 65.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.966 -0.561 . . . . 1.6200000000000001 111.26 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.463 ' HA ' HD13 ' A' ' 215' ' ' ILE . 11.4 m -51.97 -28.46 16.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.205 -0.452 . . . . 1.3 111.619 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.86 -40.08 60.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.777 0.322 . . . . 1.4099999999999999 110.571 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 49.4 m95 -74.98 -34.72 62.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.446 . . . . 1.45 110.053 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.463 HD13 ' HA ' ' A' ' 212' ' ' THR . 1.8 mp -57.85 -39.9 73.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 116.038 -0.528 . . . . 0.91000000000000003 109.833 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 46.2 t -60.57 -35.2 75.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.265 -0.643 . . . . 1.3500000000000001 109.265 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 87.4 t -75.5 -29.94 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 115.244 -0.889 . . . . 0.47999999999999998 110.01 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 215' ' ' ILE . . . -59.32 -43.98 92.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.533 -0.758 . . . . 0.27000000000000002 110.716 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 223' ' ' VAL . 23.8 t -64.68 -40.04 87.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.611 -0.722 . . . . 0.27000000000000002 111.317 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 9.9 mt -54.6 -41.97 70.56 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.866 0.365 . . . . 0.27000000000000002 110.496 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.488 ' O ' HG13 ' A' ' 224' ' ' ILE . 51.2 m -54.29 -41.51 68.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.875 -0.602 . . . . 1.1399999999999999 109.892 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.422 ' O ' HD13 ' A' ' 226' ' ' LEU . . . -72.95 -36.26 67.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.941 -0.572 . . . . 0.38 110.729 178.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 219' ' ' VAL . 74.9 t -57.27 -48.11 83.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.853 -0.612 . . . . 0.48999999999999999 112.027 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 221' ' ' SER . 2.2 pp -56.39 -35.83 44.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.958 0.409 . . . . 0.51000000000000001 110.753 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 51.1 t -66.46 -37.47 85.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.058 -0.519 . . . . 1.3600000000000001 110.56 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 222' ' ' ALA . 9.6 mp -66.17 -52.53 47.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.895 -0.593 . . . . 0.51000000000000001 111.655 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.514 HG13 ' N ' ' A' ' 228' ' ' ILE . 17.6 pt -55.46 -35.81 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.638 -0.256 . . . . 0.46000000000000002 111.655 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.514 ' N ' HG13 ' A' ' 227' ' ' ILE . 82.9 mt -62.24 -39.06 82.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.08 0.467 . . . . 0.35999999999999999 110.271 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 77.7 t -57.09 -49.95 77.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.499 -0.773 . . . . 0.29999999999999999 110.794 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -72.45 -37.93 68.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.58999999999999997 110.882 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -64.93 -7.16 10.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.642 -0.708 . . . . 0.28999999999999998 111.793 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 232' ' ' VAL . 74.6 t -117.77 -0.95 8.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.836 0.827 . . . . 0.51000000000000001 110.107 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.04 -4.49 11.03 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.206 -1.035 . . . . 0.52000000000000002 108.206 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 6.8 mp -119.93 10.77 11.62 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 113.843 -1.526 . . . . 0.59999999999999998 108.319 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.1 mptt -114.69 -14.85 12.0 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.061 -0.972 . . . . 0.81999999999999995 111.29 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 150.56 59.02 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.713 -0.756 . . . . 1.97 112.65 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -67.59 -34.62 77.39 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.87 0.367 . . . . 4.0 110.465 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 41.5 t -155.46 -73.23 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.968 -0.56 . . . . 5.29 110.558 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 51.1 mtm -136.49 58.11 1.75 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.067 -0.515 . . . . 6.96 110.659 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 240' ' ' VAL . 15.8 m . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.602 -0.713 . . . . 8.1199999999999992 111.427 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 112.48 -0.248 . . . . 11.27 112.48 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 81.1 p -148.06 166.27 28.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.82 0.343 . . . . 10.029999999999999 110.905 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -125.64 20.53 7.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 10.18 110.955 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 73.4 m -123.07 -69.34 0.83 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.178 -0.464 . . . . 7.9400000000000004 111.057 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 54.8 ttm -145.47 -71.86 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 6.7400000000000002 110.717 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -171.95 -82.87 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.243 -0.435 . . . . 4.9100000000000001 110.988 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.37 6.68 0.66 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 2.79 110.976 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 88.9 m -64.61 -54.01 38.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.14 -0.482 . . . . 1.6200000000000001 111.225 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 19.5 m -52.14 -23.06 4.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.079 -0.51 . . . . 1.3 111.747 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 64.3 t -54.27 -40.54 48.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.689 0.281 . . . . 1.4099999999999999 111.057 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -83.22 -32.19 26.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.304 -0.407 . . . . 1.45 110.734 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 1.8 mp -57.03 -37.78 56.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 110.006 -0.368 . . . . 0.91000000000000003 110.006 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 43.8 t -60.4 -34.98 74.7 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.208 -0.664 . . . . 1.3500000000000001 109.208 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.63 -31.38 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.32 -0.855 . . . . 0.47999999999999998 110.047 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 215' ' ' ILE . . . -58.18 -40.17 80.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.411 -0.813 . . . . 0.27000000000000002 110.674 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 223' ' ' VAL . 20.8 t -66.85 -42.73 89.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.562 -0.745 . . . . 0.27000000000000002 111.244 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.97 -44.16 63.89 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.974 0.416 . . . . 0.27000000000000002 110.507 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 49.2 m -54.06 -41.21 67.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.714 -0.676 . . . . 1.1399999999999999 110.077 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.423 ' O ' HD13 ' A' ' 226' ' ' LEU . . . -72.33 -36.11 68.77 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.036 -0.529 . . . . 0.38 110.636 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 219' ' ' VAL . 95.4 t -58.85 -53.43 47.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.112 -0.495 . . . . 0.48999999999999999 111.496 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.469 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.6 pp -58.25 -31.33 42.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-O 120.991 0.424 . . . . 0.51000000000000001 110.21 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.469 ' N ' HD12 ' A' ' 224' ' ' ILE . 58.2 m -66.96 -34.38 77.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.88 -0.6 . . . . 1.3600000000000001 110.26 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 222' ' ' ALA . 7.0 mp -70.91 -48.25 54.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.635 -0.712 . . . . 0.51000000000000001 112.198 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.518 HG13 ' N ' ' A' ' 228' ' ' ILE . 12.9 pt -56.95 -36.16 49.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 111.98 0.363 . . . . 0.46000000000000002 111.98 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.518 ' N ' HG13 ' A' ' 227' ' ' ILE . 81.3 mt -61.62 -37.65 78.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.187 0.518 . . . . 0.35999999999999999 110.3 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 79.6 t -58.68 -49.86 81.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.444 -0.798 . . . . 0.29999999999999999 111.036 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.403 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 2.1 m-90 -72.05 -38.92 69.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.07 0.462 . . . . 0.58999999999999997 110.863 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -64.16 -8.08 11.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.705 -0.68 . . . . 0.28999999999999998 111.657 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.512 ' O ' HG12 ' A' ' 232' ' ' VAL . 65.4 t -117.95 -0.44 8.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.9 0.857 . . . . 0.51000000000000001 110.042 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 237' ' ' TYR . . . -118.22 -2.93 11.08 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.14 -1.059 . . . . 0.52000000000000002 108.14 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 8.0 mp -120.02 8.74 11.06 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 113.917 -1.492 . . . . 0.59999999999999998 108.09 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.2 mptt -115.08 3.15 14.35 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.712 -1.131 . . . . 0.81999999999999995 111.28 -178.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 166.49 47.8 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.634 -0.793 . . . . 1.97 112.669 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.453 ' HB3' ' O ' ' A' ' 233' ' ' ALA . 14.2 p90 -70.97 -2.26 14.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.818 0.342 . . . . 4.0 111.095 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 47.9 t -75.57 -12.08 60.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.279 -0.419 . . . . 5.29 110.919 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 55.5 mtt -116.96 37.07 3.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 6.96 111.056 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.406 ' H ' HG22 ' A' ' 240' ' ' VAL . 2.2 m . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.382 -0.818 . . . . 8.1199999999999992 111.298 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 112.511 -0.236 . . . . 11.27 112.511 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 74.7 p -105.81 88.81 2.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.92 0.391 . . . . 10.029999999999999 110.732 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -88.67 18.04 5.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 10.18 111.114 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 48.4 p 49.64 45.77 24.15 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.957 -0.565 . . . . 7.9400000000000004 111.488 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 56.9 ttp -84.1 145.53 28.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 6.7400000000000002 110.968 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -118.07 151.85 36.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.447 . . . . 4.9100000000000001 110.838 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.9 86.61 0.24 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.127 -0.488 . . . . 2.79 111.245 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.406 ' O ' HD13 ' A' ' 215' ' ' ILE . 59.0 m -97.45 -64.11 1.07 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.072 -0.513 . . . . 1.6200000000000001 111.16 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.434 ' HA ' ' HB ' ' A' ' 215' ' ' ILE . 30.5 m -51.89 -26.66 10.67 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.192 -0.458 . . . . 1.3 110.764 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 50.2 t -55.43 -41.65 63.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.8 -0.636 . . . . 1.4099999999999999 110.571 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -83.55 -28.9 28.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.982 -0.554 . . . . 1.45 110.871 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.434 ' HB ' ' HA ' ' A' ' 212' ' ' THR . 1.7 mp -55.19 -43.24 69.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.488 -0.324 . . . . 0.91000000000000003 110.348 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 48.0 t -57.7 -35.96 71.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.387 0.613 . . . . 1.3500000000000001 109.382 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 87.2 t -75.33 -30.1 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 115.19 -0.914 . . . . 0.47999999999999998 110.16 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 215' ' ' ILE . . . -58.38 -39.09 78.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.598 -0.728 . . . . 0.27000000000000002 110.669 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 15.1 t -69.02 -38.1 77.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.518 -0.765 . . . . 0.27000000000000002 111.114 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 13.8 mt -57.69 -47.35 82.57 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 120.851 0.358 . . . . 0.27000000000000002 110.378 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 50.4 m -54.45 -36.06 63.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.832 -0.622 . . . . 1.1399999999999999 110.061 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.492 ' O ' HD13 ' A' ' 226' ' ' LEU . . . -72.6 -45.47 58.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.974 -0.557 . . . . 0.38 110.738 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 69.4 t -57.31 -50.79 75.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.03 -0.532 . . . . 0.48999999999999999 111.509 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.418 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.7 pp -60.69 -31.82 50.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.011 0.434 . . . . 0.51000000000000001 110.244 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.418 ' N ' HD12 ' A' ' 224' ' ' ILE . 35.0 t -66.94 -35.11 79.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.963 -0.562 . . . . 1.3600000000000001 110.147 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.492 HD13 ' O ' ' A' ' 222' ' ' ALA . 7.4 mp -63.64 -50.5 69.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.575 -0.739 . . . . 0.51000000000000001 111.877 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.514 HG13 ' N ' ' A' ' 228' ' ' ILE . 11.5 pt -59.24 -35.99 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.798 -0.183 . . . . 0.46000000000000002 111.484 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.514 ' N ' HG13 ' A' ' 227' ' ' ILE . 82.7 mt -61.6 -37.79 78.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.194 0.521 . . . . 0.35999999999999999 110.223 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 65.4 t -56.79 -48.85 80.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.453 -0.794 . . . . 0.29999999999999999 110.873 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.412 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 2.4 m-90 -72.36 -40.23 67.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.047 -0.524 . . . . 0.58999999999999997 110.845 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -66.52 -7.27 18.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.7 -0.682 . . . . 0.28999999999999998 111.616 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.521 ' O ' HG12 ' A' ' 232' ' ' VAL . 71.3 t -118.0 -0.06 8.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.931 0.872 . . . . 0.51000000000000001 109.983 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.29 -3.85 10.97 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.123 -1.065 . . . . 0.52000000000000002 108.123 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.3 mp -119.97 9.92 11.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 113.937 -1.483 . . . . 0.59999999999999998 108.273 178.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.2 mptt -114.99 -56.33 2.39 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.02 -0.991 . . . . 0.81999999999999995 111.832 -178.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -138.18 39.66 1.56 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.035 -0.602 . . . . 1.97 112.891 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -62.35 -18.52 61.66 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.771 0.32 . . . . 4.0 111.27 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 41.6 t -82.6 -34.72 27.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.401 -0.363 . . . . 5.29 111.127 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 71.0 mtm -103.1 40.46 1.39 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.279 -0.419 . . . . 6.96 111.08 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.434 HG22 ' H ' ' A' ' 240' ' ' VAL . 2.4 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.025 -0.988 . . . . 8.1199999999999992 111.303 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 112.563 -0.215 . . . . 11.27 112.563 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.406 ' HB3' ' HG3' ' A' ' 208' ' ' MET . 48.7 m -67.98 157.71 34.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.703 0.287 . . . . 10.029999999999999 110.868 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -100.2 118.52 36.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.321 -0.4 . . . . 10.18 111.03 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 24.3 m 59.65 -90.33 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.045 -0.525 . . . . 7.9400000000000004 111.243 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.406 ' HG3' ' HB3' ' A' ' 205' ' ' SER . 24.5 mmt 54.23 44.84 28.48 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.318 -0.401 . . . . 6.7400000000000002 111.365 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -68.02 114.36 6.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.444 -0.344 . . . . 4.9100000000000001 110.788 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -79.09 -14.74 58.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 2.79 111.32 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 88.8 m -56.05 -52.38 64.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.225 -0.443 . . . . 1.6200000000000001 111.309 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.439 ' HA ' HD13 ' A' ' 215' ' ' ILE . 36.3 m -52.96 -28.3 23.09 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.077 -0.51 . . . . 1.3 111.882 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 53.6 t -54.35 -39.5 44.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.871 0.367 . . . . 1.4099999999999999 110.965 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -83.43 -24.99 31.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.07 -0.513 . . . . 1.45 110.945 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 212' ' ' THR . 1.7 mp -56.52 -42.19 74.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.58 -0.282 . . . . 0.91000000000000003 110.527 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 80.5 p -57.63 -35.32 70.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.4 0.619 . . . . 1.3500000000000001 109.365 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 92.7 t -75.25 -32.48 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.186 -0.915 . . . . 0.47999999999999998 110.058 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.33 91.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.44 -0.8 . . . . 0.27000000000000002 110.572 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 24.3 t -63.73 -37.32 79.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.705 -0.679 . . . . 0.27000000000000002 110.732 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 13.0 mt -57.63 -41.44 81.36 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.009 0.433 . . . . 0.27000000000000002 109.983 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.417 ' O ' HG13 ' A' ' 224' ' ' ILE . 45.7 t -54.14 -37.63 64.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.603 -0.726 . . . . 1.1399999999999999 109.741 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.491 ' O ' HD13 ' A' ' 226' ' ' LEU . . . -72.74 -40.19 66.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.788 -0.642 . . . . 0.38 110.347 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 87.8 t -57.24 -53.48 43.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 115.863 -0.608 . . . . 0.48999999999999999 111.7 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.438 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.6 pp -56.48 -33.86 39.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.023 0.439 . . . . 0.51000000000000001 110.453 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.438 ' N ' HD12 ' A' ' 224' ' ' ILE . 38.6 t -67.55 -35.01 78.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.972 -0.558 . . . . 1.3600000000000001 110.328 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.491 HD13 ' O ' ' A' ' 222' ' ' ALA . 7.3 mp -68.31 -49.87 57.4 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.555 -0.748 . . . . 0.51000000000000001 112.214 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.52 HG13 ' N ' ' A' ' 228' ' ' ILE . 4.4 pt -53.76 -36.25 29.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.593 0.235 . . . . 0.46000000000000002 111.433 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.52 ' N ' HG13 ' A' ' 227' ' ' ILE . 65.6 mt -66.22 -38.0 80.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.073 0.463 . . . . 0.35999999999999999 110.146 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 225' ' ' CYS . 79.0 t -59.05 -46.05 92.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.646 -0.706 . . . . 0.29999999999999999 110.717 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.446 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 1.9 m-90 -71.95 -41.66 67.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.08 0.467 . . . . 0.58999999999999997 110.2 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -64.79 -8.3 14.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.66 -0.7 . . . . 0.28999999999999998 111.295 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.499 ' O ' HG12 ' A' ' 232' ' ' VAL . 60.7 t -118.31 -1.06 8.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.849 0.833 . . . . 0.51000000000000001 109.9 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 237' ' ' TYR . . . -118.09 -1.97 11.31 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.272 -1.01 . . . . 0.52000000000000002 108.272 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 8.6 mp -120.46 7.78 10.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 113.907 -1.497 . . . . 0.59999999999999998 107.805 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.3 mptt -115.56 -21.69 9.61 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.852 -1.067 . . . . 0.81999999999999995 112.009 -178.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -148.93 25.4 1.29 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.515 -0.85 . . . . 1.97 113.169 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.537 ' HB3' ' O ' ' A' ' 233' ' ' ALA . 38.2 p90 -67.05 -7.49 23.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.727 0.298 . . . . 4.0 110.945 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 52.1 m -84.95 -38.21 19.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 5.29 111.077 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 85.3 mtp -94.13 35.65 1.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 6.96 111.133 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.435 HG22 ' H ' ' A' ' 240' ' ' VAL . 2.3 m . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.148 -0.929 . . . . 8.1199999999999992 111.325 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.462 -0.255 . . . . 11.27 112.462 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 50.1 m -113.49 138.59 49.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.829 0.347 . . . . 10.029999999999999 110.917 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -107.86 30.17 6.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.04 -0.527 . . . . 10.18 110.75 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 60.3 p -67.33 -16.41 64.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 7.9400000000000004 111.053 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 65.8 mtm -127.7 84.15 2.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 6.7400000000000002 110.818 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -60.64 131.24 50.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 4.9100000000000001 110.689 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -83.94 21.51 1.31 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 2.79 110.933 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.44 ' O ' HD13 ' A' ' 215' ' ' ILE . 90.4 m -54.92 -55.52 29.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.396 . . . . 1.6200000000000001 110.764 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.411 ' HA ' ' HB ' ' A' ' 215' ' ' ILE . 17.5 m -53.39 -27.06 22.06 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.935 -0.575 . . . . 1.3 111.55 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 47.4 t -59.19 -38.66 75.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.837 0.351 . . . . 1.4099999999999999 110.64 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -82.72 -23.37 34.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.194 -0.457 . . . . 1.45 110.42 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 211' ' ' THR . 1.7 mp -65.26 -48.43 83.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.208 -0.451 . . . . 0.91000000000000003 110.255 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 81.7 p -58.4 -36.07 73.0 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.298 -0.63 . . . . 1.3500000000000001 109.298 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 91.4 t -75.46 -29.89 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.315 -0.857 . . . . 0.47999999999999998 109.904 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.2 -38.83 90.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.344 -0.843 . . . . 0.27000000000000002 110.609 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 223' ' ' VAL . 21.6 t -69.46 -34.47 62.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.658 -0.701 . . . . 0.27000000000000002 111.415 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 14.0 mt -59.59 -48.71 80.59 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 120.83 0.347 . . . . 0.27000000000000002 110.692 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 224' ' ' ILE . 94.5 p -54.82 -36.19 64.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.181 0.515 . . . . 1.1399999999999999 109.799 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.49 ' O ' HD13 ' A' ' 226' ' ' LEU . . . -73.0 -37.93 66.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.701 -0.681 . . . . 0.38 110.74 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 219' ' ' VAL . 39.6 t -58.99 -52.56 59.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.093 -0.503 . . . . 0.48999999999999999 111.817 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.7 pp -55.97 -33.35 35.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.909 0.385 . . . . 0.51000000000000001 110.471 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.475 ' N ' HD12 ' A' ' 224' ' ' ILE . 51.2 t -67.4 -34.94 78.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.021 -0.536 . . . . 1.3600000000000001 110.461 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 222' ' ' ALA . 8.2 mp -70.21 -51.91 27.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.643 -0.708 . . . . 0.51000000000000001 112.105 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.512 HG13 ' N ' ' A' ' 228' ' ' ILE . 4.8 pt -53.59 -36.24 27.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 111.729 0.27 . . . . 0.46000000000000002 111.729 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.512 ' N ' HG13 ' A' ' 227' ' ' ILE . 83.4 mt -65.04 -37.5 80.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.042 0.448 . . . . 0.35999999999999999 110.261 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 225' ' ' CYS . 78.6 t -60.58 -48.18 89.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.562 -0.745 . . . . 0.29999999999999999 111.075 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.451 ' HZ3' ' HB3' ' A' ' 226' ' ' LEU . 1.8 m-90 -71.85 -40.26 69.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.015 0.436 . . . . 0.58999999999999997 110.634 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.15 -8.16 7.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.808 -0.633 . . . . 0.28999999999999998 111.581 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.504 ' O ' HG12 ' A' ' 232' ' ' VAL . 63.3 t -118.12 -1.82 9.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.794 0.807 . . . . 0.51000000000000001 110.279 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -117.96 -2.17 11.34 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.263 -1.014 . . . . 0.52000000000000002 108.263 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.8 mp -119.99 8.3 11.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 113.801 -1.545 . . . . 0.59999999999999998 107.956 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -114.81 36.66 3.74 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.688 -1.142 . . . . 0.81999999999999995 111.018 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 163.21 0.67 0.05 OUTLIER Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.752 -0.737 . . . . 1.97 113.075 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.91 -23.15 27.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.787 0.327 . . . . 4.0 110.676 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 47.6 t -71.34 -17.37 62.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.017 -0.538 . . . . 5.29 110.964 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 66.8 mtm -111.91 40.41 2.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.391 -0.368 . . . . 6.96 111.252 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.17 -0.919 . . . . 8.1199999999999992 111.125 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 112.411 -0.275 . . . . 11.27 112.411 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 59.5 m -150.86 143.62 24.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 10.029999999999999 110.998 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -151.53 13.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 10.18 110.667 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 60.1 m -126.0 94.08 4.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.116 -0.493 . . . . 7.9400000000000004 111.097 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -75.62 -170.17 1.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 6.7400000000000002 110.865 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -55.19 -74.3 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.245 -0.434 . . . . 4.9100000000000001 110.98 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.7 6.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 2.79 110.818 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 99.9 m -60.6 -53.9 51.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.442 . . . . 1.6200000000000001 111.009 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.494 ' HA ' HD13 ' A' ' 215' ' ' ILE . 15.4 m -53.2 -23.95 9.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 1.3 111.711 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 58.7 t -58.96 -36.88 64.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.916 0.388 . . . . 1.4099999999999999 110.512 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -80.81 -31.05 35.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.035 -0.53 . . . . 1.45 110.306 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' A' ' 212' ' ' THR . 1.8 mp -58.62 -42.9 86.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.258 -0.428 . . . . 0.91000000000000003 110.098 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 46.9 t -60.9 -35.58 77.02 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.223 -0.658 . . . . 1.3500000000000001 109.223 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 86.3 t -73.59 -29.41 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.276 -0.875 . . . . 0.47999999999999998 110.04 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 215' ' ' ILE . . . -54.34 -46.69 72.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.514 -0.766 . . . . 0.27000000000000002 110.87 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 19.5 t -65.67 -41.09 89.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.974 -0.557 . . . . 0.27000000000000002 111.058 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 11.8 mt -54.3 -41.18 68.65 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.901 0.382 . . . . 0.27000000000000002 110.197 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.418 ' O ' HG13 ' A' ' 224' ' ' ILE . 53.9 m -54.15 -41.61 68.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.724 -0.671 . . . . 1.1399999999999999 110.243 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.4 -39.54 67.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.021 -0.536 . . . . 0.38 110.691 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 97.6 t -59.2 -53.1 52.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.114 -0.494 . . . . 0.48999999999999999 111.279 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.429 ' HA ' HG12 ' A' ' 227' ' ' ILE . 2.7 pp -58.55 -31.85 44.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.136 0.494 . . . . 0.51000000000000001 110.184 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.428 ' N ' HD12 ' A' ' 224' ' ' ILE . 19.0 m -66.63 -34.42 77.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.576 -0.738 . . . . 1.3600000000000001 110.276 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.45 -53.07 21.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.672 -0.695 . . . . 0.51000000000000001 111.733 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.518 HG13 ' N ' ' A' ' 228' ' ' ILE . 10.9 pt -55.19 -36.2 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.154 0.427 . . . . 0.46000000000000002 112.154 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.518 ' N ' HG13 ' A' ' 227' ' ' ILE . 81.0 mt -62.44 -37.75 79.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.109 0.48 . . . . 0.35999999999999999 110.438 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 67.8 t -59.1 -50.01 81.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.46 -0.791 . . . . 0.29999999999999999 111.063 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 3.1 m-90 -71.77 -36.39 70.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.58999999999999997 110.901 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -65.28 -7.04 11.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.648 -0.705 . . . . 0.28999999999999998 111.604 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 232' ' ' VAL . 71.6 t -117.87 -0.78 8.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.892 0.854 . . . . 0.51000000000000001 109.953 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.01 -3.56 11.12 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.19 -1.041 . . . . 0.52000000000000002 108.19 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 7.5 mp -120.02 9.03 11.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 113.961 -1.472 . . . . 0.59999999999999998 108.278 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 0.9 OUTLIER -115.14 46.96 1.35 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 114.983 -1.008 . . . . 0.81999999999999995 111.656 -178.131 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 145.97 -1.13 0.9 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.497 -0.858 . . . . 1.97 112.959 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.95 -23.57 14.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.901 0.382 . . . . 4.0 110.864 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 43.3 t -68.67 -7.47 33.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 5.29 111.071 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 48.8 mtm -124.64 35.83 4.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.428 -0.351 . . . . 6.96 111.198 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.427 HG22 ' H ' ' A' ' 240' ' ' VAL . 2.4 m . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.504 -0.76 . . . . 8.1199999999999992 111.222 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.444 -0.262 . . . . 11.27 112.444 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 47.2 t 61.12 -84.28 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.738 0.304 . . . . 10.029999999999999 111.179 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -86.05 93.72 9.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.881 0.372 . . . . 10.18 110.818 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 87.7 m -154.67 -66.59 0.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 7.9400000000000004 111.035 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 91.8 mmm 64.18 118.4 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.145 -0.48 . . . . 6.7400000000000002 111.317 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -120.16 112.95 19.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 4.9100000000000001 110.937 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -176.21 7.5 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.014 -0.539 . . . . 2.79 110.63 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.425 ' O ' HD13 ' A' ' 215' ' ' ILE . 60.4 m -53.28 -56.2 18.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 1.6200000000000001 111.646 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 14.9 m -52.19 -26.3 11.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 1.3 112.036 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 59.0 t -61.05 -40.09 84.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.822 0.344 . . . . 1.4099999999999999 110.841 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 48.7 m95 -78.8 -28.0 44.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.176 -0.466 . . . . 1.45 110.058 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.434 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 1.7 mp -59.84 -41.12 84.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.028 -0.533 . . . . 0.91000000000000003 110.279 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 49.4 m -60.11 -35.7 75.82 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.27 -0.641 . . . . 1.3500000000000001 109.27 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 98.4 t -74.11 -29.9 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 115.188 -0.914 . . . . 0.47999999999999998 110.196 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 215' ' ' ILE . . . -55.7 -41.89 74.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.568 -0.742 . . . . 0.27000000000000002 110.842 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 24.9 t -67.46 -41.98 86.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.719 -0.673 . . . . 0.27000000000000002 111.214 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 13.6 mt -52.51 -44.38 65.66 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.965 0.412 . . . . 0.27000000000000002 110.428 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.409 ' O ' HG13 ' A' ' 224' ' ' ILE . 56.6 m -54.17 -41.1 68.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.766 -0.652 . . . . 1.1399999999999999 110.155 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.09 -36.9 69.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 0.38 110.847 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 76.7 t -60.94 -53.07 54.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-N 116.151 -0.477 . . . . 0.48999999999999999 111.358 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.7 pp -59.74 -31.8 48.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.163 0.506 . . . . 0.51000000000000001 110.085 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.44 ' HA ' HD12 ' A' ' 228' ' ' ILE . 33.6 m -66.55 -34.83 78.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.708 -0.678 . . . . 1.3600000000000001 110.273 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.1 mp -62.12 -55.23 30.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.688 -0.687 . . . . 0.51000000000000001 111.687 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.521 HG13 ' N ' ' A' ' 228' ' ' ILE . 16.2 pt -55.67 -35.78 40.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.486 -0.325 . . . . 0.46000000000000002 111.806 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.521 ' N ' HG13 ' A' ' 227' ' ' ILE . 83.8 mt -62.14 -39.67 84.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.149 0.5 . . . . 0.35999999999999999 110.248 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 79.2 t -56.41 -48.25 80.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.485 -0.779 . . . . 0.29999999999999999 110.663 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.418 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 3.0 m-90 -72.43 -39.79 67.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.003 -0.544 . . . . 0.58999999999999997 110.861 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -67.14 -7.21 21.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.614 -0.721 . . . . 0.28999999999999998 111.493 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.521 ' O ' HG12 ' A' ' 232' ' ' VAL . 62.8 t -117.96 -0.06 8.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.836 0.827 . . . . 0.51000000000000001 109.95 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.18 -4.31 10.99 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.097 -1.075 . . . . 0.52000000000000002 108.097 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.1 mp -119.94 9.45 11.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.873 -1.512 . . . . 0.59999999999999998 108.342 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 0.8 OUTLIER -114.76 -1.59 13.21 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.884 -1.053 . . . . 0.81999999999999995 111.039 -178.6 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 134.77 58.07 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.875 -0.679 . . . . 1.97 112.291 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.416 ' HA ' HG13 ' A' ' 240' ' ' VAL . 30.2 p90 -66.97 -4.2 9.01 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.339 -0.43 . . . . 4.0 111.2 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 53.9 m -79.95 -33.38 39.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.306 -0.407 . . . . 5.29 111.37 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 55.5 mtm -125.53 42.58 3.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.407 -0.36 . . . . 6.96 111.567 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.448 HG22 ' H ' ' A' ' 240' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.105 -0.95 . . . . 8.1199999999999992 111.165 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.576 -0.21 . . . . 11.27 112.576 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 53.9 m -140.77 130.9 24.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.762 0.315 . . . . 10.029999999999999 110.903 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -136.12 129.04 31.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 10.18 110.959 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.607 HG22 ' HG2' ' A' ' 208' ' ' MET . 27.0 m -101.14 141.05 34.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.073 -0.512 . . . . 7.9400000000000004 110.901 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.607 ' HG2' HG22 ' A' ' 207' ' ' THR . 25.3 mmt 63.07 -82.21 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.166 -0.47 . . . . 6.7400000000000002 111.195 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -60.95 143.12 55.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.92 0.391 . . . . 4.9100000000000001 110.965 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -167.28 12.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.995 -0.548 . . . . 2.79 110.553 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 91.4 m -57.77 -53.11 61.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.046 -0.524 . . . . 1.6200000000000001 111.276 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 12.9 m -53.39 -27.23 22.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 1.3 111.805 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.18 -34.38 56.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.87 0.367 . . . . 1.4099999999999999 110.533 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -82.03 -29.6 31.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.07 -0.514 . . . . 1.45 110.111 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.433 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 1.7 mp -61.37 -45.24 99.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.058 -0.519 . . . . 0.91000000000000003 110.021 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.417 ' O ' ' HG ' ' A' ' 220' ' ' LEU . 78.3 p -59.04 -34.93 72.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.18 -0.674 . . . . 1.3500000000000001 109.18 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 87.4 t -74.9 -29.65 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.293 -0.867 . . . . 0.47999999999999998 110.221 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 215' ' ' ILE . . . -59.0 -45.38 90.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.463 -0.79 . . . . 0.27000000000000002 110.814 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 223' ' ' VAL . 19.5 t -64.35 -41.01 91.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.672 -0.695 . . . . 0.27000000000000002 111.416 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 216' ' ' SER . 11.3 mt -52.71 -43.31 65.56 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.819 0.342 . . . . 0.27000000000000002 110.599 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.42 ' O ' HG13 ' A' ' 224' ' ' ILE . 55.5 m -54.42 -41.35 69.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.947 -0.57 . . . . 1.1399999999999999 110.133 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.427 ' O ' HD13 ' A' ' 226' ' ' LEU . . . -72.66 -38.01 67.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.036 -0.529 . . . . 0.38 110.903 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 219' ' ' VAL . 92.4 t -61.2 -51.68 70.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 115.996 -0.547 . . . . 0.48999999999999999 111.843 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.498 ' HA ' HG12 ' A' ' 227' ' ' ILE . 2.6 pp -56.11 -32.57 34.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.92 0.39 . . . . 0.51000000000000001 110.416 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.448 ' N ' HD12 ' A' ' 224' ' ' ILE . 53.0 t -67.12 -35.41 79.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.509 . . . . 1.3600000000000001 110.297 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 222' ' ' ALA . 8.3 mp -71.41 -49.05 45.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.731 -0.668 . . . . 0.51000000000000001 111.8 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.535 HG13 ' N ' ' A' ' 228' ' ' ILE . 12.5 pt -57.31 -36.1 51.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.668 -0.242 . . . . 0.46000000000000002 111.572 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.535 ' N ' HG13 ' A' ' 227' ' ' ILE . 81.5 mt -63.14 -37.61 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.147 0.498 . . . . 0.35999999999999999 110.165 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 225' ' ' CYS . 74.9 t -60.82 -47.99 90.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.524 -0.762 . . . . 0.29999999999999999 110.949 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.42 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 2.2 m-90 -72.22 -40.94 67.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.049 0.452 . . . . 0.58999999999999997 110.871 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -64.15 -7.73 9.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.672 -0.695 . . . . 0.28999999999999998 111.562 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 232' ' ' VAL . 68.3 t -118.02 -0.71 8.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.769 0.795 . . . . 0.51000000000000001 110.133 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.25 -3.99 10.98 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.127 -1.064 . . . . 0.52000000000000002 108.127 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.4 mp -119.79 8.95 11.23 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 113.894 -1.503 . . . . 0.59999999999999998 108.119 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.1 mptt -115.05 -7.12 12.52 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.911 -1.041 . . . . 0.81999999999999995 111.187 -178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 165.65 -12.3 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.771 -0.728 . . . . 1.97 112.677 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 32.9 p90 34.21 35.3 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.614 0.598 . . . . 4.0 112.614 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 61.5 m -91.6 -31.49 15.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.374 -0.376 . . . . 5.29 111.125 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 62.7 mtt -109.34 37.12 2.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 6.96 110.974 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.463 -0.779 . . . . 8.1199999999999992 111.198 179.963 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 112.571 -0.212 . . . . 11.27 112.571 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 43.6 t -132.19 -58.98 0.94 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.733 0.301 . . . . 10.029999999999999 110.951 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 55.02 81.37 0.11 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.144 -0.48 . . . . 10.18 111.107 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 73.5 p -108.63 47.9 0.89 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.081 -0.508 . . . . 7.9400000000000004 111.2 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 10.8 tmm? -155.62 -51.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 6.7400000000000002 110.713 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -88.23 1.17 55.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.485 . . . . 4.9100000000000001 111.005 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -62.83 -19.84 64.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 2.79 111.241 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 92.4 m -54.47 -56.07 22.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.32 -0.4 . . . . 1.6200000000000001 110.957 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 13.5 m -53.66 -25.14 16.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.002 -0.544 . . . . 1.3 111.848 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 48.4 t -57.72 -37.62 60.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.799 0.333 . . . . 1.4099999999999999 110.76 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 62.2 m95 -81.84 -31.79 31.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.203 -0.453 . . . . 1.45 110.355 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.0 -40.21 62.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 116.263 -0.426 . . . . 0.91000000000000003 110.02 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 61.9 m -58.42 -35.16 71.65 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.377 -0.601 . . . . 1.3500000000000001 109.377 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 92.9 t -75.07 -29.89 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.481 -0.781 . . . . 0.47999999999999998 110.151 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.14 -40.95 97.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.526 -0.761 . . . . 0.27000000000000002 110.788 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 223' ' ' VAL . 21.1 t -66.08 -37.06 78.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.66 -0.7 . . . . 0.27000000000000002 111.407 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 12.0 mt -55.92 -44.7 78.55 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 120.917 0.389 . . . . 0.27000000000000002 110.458 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.477 ' O ' HG13 ' A' ' 224' ' ' ILE . 47.9 t -54.3 -39.41 66.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.794 -0.639 . . . . 1.1399999999999999 110.219 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.417 ' O ' HD13 ' A' ' 226' ' ' LEU . . . -73.04 -39.31 66.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.978 -0.555 . . . . 0.38 110.851 178.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 219' ' ' VAL . 62.0 t -57.44 -50.45 76.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 115.948 -0.569 . . . . 0.48999999999999999 112.018 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 221' ' ' SER . 2.6 pp -56.56 -33.26 39.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.93 0.395 . . . . 0.51000000000000001 110.667 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.433 ' N ' HD12 ' A' ' 224' ' ' ILE . 51.5 t -67.36 -35.15 78.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 1.3600000000000001 110.566 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 222' ' ' ALA . 8.8 mp -67.1 -50.29 62.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.764 -0.653 . . . . 0.51000000000000001 111.932 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.546 HG13 ' N ' ' A' ' 228' ' ' ILE . 10.2 pt -55.82 -36.22 42.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 111.593 0.22 . . . . 0.46000000000000002 111.593 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.546 ' N ' HG13 ' A' ' 227' ' ' ILE . 75.2 mt -62.55 -37.97 80.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.052 0.453 . . . . 0.35999999999999999 110.166 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 75.4 t -58.06 -48.05 85.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.492 -0.776 . . . . 0.29999999999999999 110.673 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.428 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 2.5 m-90 -71.95 -38.85 69.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.082 -0.508 . . . . 0.58999999999999997 110.522 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.6 -7.37 14.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.719 -0.673 . . . . 0.28999999999999998 111.472 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 232' ' ' VAL . 68.0 t -117.57 -1.28 9.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.75 0.786 . . . . 0.51000000000000001 109.938 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 237' ' ' TYR . . . -118.28 -3.62 10.99 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.087 -1.079 . . . . 0.52000000000000002 108.087 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.0 mp -120.17 12.3 11.81 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 113.994 -1.457 . . . . 0.59999999999999998 108.413 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.06 50.26 0.94 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.104 -0.953 . . . . 0.81999999999999995 110.713 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 136.94 14.23 0.88 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.606 -0.724 . . . . 1.97 112.266 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.458 ' HB2' ' O ' ' A' ' 233' ' ' ALA . 39.1 m-85 -127.66 -7.12 5.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.767 0.318 . . . . 4.0 111.066 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 11.2 t -102.43 -43.41 5.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 5.29 110.891 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 77.3 mtp -86.66 32.38 0.66 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.901 -0.59 . . . . 6.96 111.325 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.567 -0.73 . . . . 8.1199999999999992 111.396 -179.986 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.478 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.7 pp . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 121.059 0.456 . . . . 0.51 110.232 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.478 ' N ' HD12 ' A' ' 224' ' ' ILE . 54.8 m -66.99 -34.57 78.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.817 -0.629 . . . . 1.36 110.288 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 6.2 mp -69.12 -52.47 27.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.661 -0.7 . . . . 0.51 111.921 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.527 HG13 ' N ' ' A' ' 228' ' ' ILE . 9.9 pt -53.58 -36.0 27.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 111.945 0.35 . . . . 0.46 111.945 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.527 ' N ' HG13 ' A' ' 227' ' ' ILE . 84.2 mt -61.7 -37.33 77.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.162 0.506 . . . . 0.36 110.366 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 75.1 t -61.96 -49.05 85.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.45 -0.795 . . . . 0.3 111.268 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -71.61 -37.11 70.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.161 0.505 . . . . 0.59 110.951 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -62.45 -7.18 4.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.573 -0.74 . . . . 0.29 111.801 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 232' ' ' VAL . 78.0 t -117.84 -1.44 9.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.683 0.754 . . . . 0.51 110.283 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.15 -3.69 11.05 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.073 -1.084 . . . . 0.52 108.073 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 7.7 mp -120.07 10.57 11.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 113.84 -1.527 . . . . 0.6 108.343 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.2 mptt . . . . . 0 N--CA 1.452 -0.353 0 CA-C-N 115.019 -0.992 . . . . 0.82 111.472 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 CA--C 1.524 -0.041 0 CA-C-O 120.958 0.409 . . . . 0.51 110.753 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 51.1 t -66.46 -37.47 85.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.058 -0.519 . . . . 1.36 110.56 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 9.6 mp -66.17 -52.53 47.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.895 -0.593 . . . . 0.51 111.655 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.514 HG13 ' N ' ' A' ' 228' ' ' ILE . 17.6 pt -55.46 -35.81 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.638 -0.256 . . . . 0.46 111.655 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.514 ' N ' HG13 ' A' ' 227' ' ' ILE . 82.9 mt -62.24 -39.06 82.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.08 0.467 . . . . 0.36 110.271 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 77.7 t -57.09 -49.95 77.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.499 -0.773 . . . . 0.3 110.794 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -72.45 -37.93 68.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.59 110.882 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -64.93 -7.16 10.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.642 -0.708 . . . . 0.29 111.793 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 232' ' ' VAL . 74.6 t -117.77 -0.95 8.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.836 0.827 . . . . 0.51 110.107 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.04 -4.49 11.03 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.206 -1.035 . . . . 0.52 108.206 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 6.8 mp -119.93 10.77 11.62 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 113.843 -1.526 . . . . 0.6 108.319 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.1 mptt . . . . . 0 N--CA 1.45 -0.435 0 CA-C-N 115.061 -0.972 . . . . 0.82 111.29 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.469 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.6 pp . . . . . 0 CA--C 1.523 -0.091 0 CA-C-O 120.991 0.424 . . . . 0.51 110.21 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.469 ' N ' HD12 ' A' ' 224' ' ' ILE . 58.2 m -66.96 -34.38 77.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.88 -0.6 . . . . 1.36 110.26 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 7.0 mp -70.91 -48.25 54.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.635 -0.712 . . . . 0.51 112.198 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.518 HG13 ' N ' ' A' ' 228' ' ' ILE . 12.9 pt -56.95 -36.16 49.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 111.98 0.363 . . . . 0.46 111.98 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.518 ' N ' HG13 ' A' ' 227' ' ' ILE . 81.3 mt -61.62 -37.65 78.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.187 0.518 . . . . 0.36 110.3 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 79.6 t -58.68 -49.86 81.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.444 -0.798 . . . . 0.3 111.036 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.403 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 2.1 m-90 -72.05 -38.92 69.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.07 0.462 . . . . 0.59 110.863 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -64.16 -8.08 11.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.705 -0.68 . . . . 0.29 111.657 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 232' ' ' VAL . 65.4 t -117.95 -0.44 8.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.9 0.857 . . . . 0.51 110.042 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.22 -2.93 11.08 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.14 -1.059 . . . . 0.52 108.14 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 8.0 mp -120.02 8.74 11.06 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 113.917 -1.492 . . . . 0.6 108.09 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.2 mptt . . . . . 0 N--CA 1.451 -0.408 0 CA-C-N 114.712 -1.131 . . . . 0.82 111.28 -178.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.418 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.7 pp . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 121.011 0.434 . . . . 0.51 110.244 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.418 ' N ' HD12 ' A' ' 224' ' ' ILE . 35.0 t -66.94 -35.11 79.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.963 -0.562 . . . . 1.36 110.147 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 7.4 mp -63.64 -50.5 69.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.575 -0.739 . . . . 0.51 111.877 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.514 HG13 ' N ' ' A' ' 228' ' ' ILE . 11.5 pt -59.24 -35.99 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.798 -0.183 . . . . 0.46 111.484 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.514 ' N ' HG13 ' A' ' 227' ' ' ILE . 82.7 mt -61.6 -37.79 78.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.194 0.521 . . . . 0.36 110.223 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 65.4 t -56.79 -48.85 80.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.453 -0.794 . . . . 0.3 110.873 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.412 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 2.4 m-90 -72.36 -40.23 67.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.047 -0.524 . . . . 0.59 110.845 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -66.52 -7.27 18.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.7 -0.682 . . . . 0.29 111.616 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 232' ' ' VAL . 71.3 t -118.0 -0.06 8.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.931 0.872 . . . . 0.51 109.983 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.29 -3.85 10.97 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.123 -1.065 . . . . 0.52 108.123 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.3 mp -119.97 9.92 11.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 113.937 -1.483 . . . . 0.6 108.273 178.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.2 mptt . . . . . 0 N--CA 1.451 -0.413 0 CA-C-N 115.02 -0.991 . . . . 0.82 111.832 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.438 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.6 pp . . . . . 0 C--O 1.23 0.055 0 CA-C-O 121.023 0.439 . . . . 0.51 110.453 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.438 ' N ' HD12 ' A' ' 224' ' ' ILE . 38.6 t -67.55 -35.01 78.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.972 -0.558 . . . . 1.36 110.328 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.31 -49.87 57.4 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.555 -0.748 . . . . 0.51 112.214 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.52 HG13 ' N ' ' A' ' 228' ' ' ILE . 4.4 pt -53.76 -36.25 29.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.593 0.235 . . . . 0.46 111.433 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.52 ' N ' HG13 ' A' ' 227' ' ' ILE . 65.6 mt -66.22 -38.0 80.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.073 0.463 . . . . 0.36 110.146 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 225' ' ' CYS . 79.0 t -59.05 -46.05 92.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.646 -0.706 . . . . 0.3 110.717 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.446 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 1.9 m-90 -71.95 -41.66 67.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.08 0.467 . . . . 0.59 110.2 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -64.79 -8.3 14.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.66 -0.7 . . . . 0.29 111.295 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . 0.499 HG12 ' O ' ' A' ' 232' ' ' VAL . 60.7 t -118.31 -1.06 8.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.849 0.833 . . . . 0.51 109.9 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.09 -1.97 11.31 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.272 -1.01 . . . . 0.52 108.272 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 8.6 mp -120.46 7.78 10.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 113.907 -1.497 . . . . 0.6 107.805 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.3 mptt . . . . . 0 N--CA 1.45 -0.47 0 CA-C-N 114.852 -1.067 . . . . 0.82 112.009 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.7 pp . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.909 0.385 . . . . 0.51 110.471 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.475 ' N ' HD12 ' A' ' 224' ' ' ILE . 51.2 t -67.4 -34.94 78.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.021 -0.536 . . . . 1.36 110.461 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.451 ' HB3' ' HZ3' ' A' ' 230' ' ' TRP . 8.2 mp -70.21 -51.91 27.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.643 -0.708 . . . . 0.51 112.105 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.512 HG13 ' N ' ' A' ' 228' ' ' ILE . 4.8 pt -53.59 -36.24 27.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 111.729 0.27 . . . . 0.46 111.729 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.512 ' N ' HG13 ' A' ' 227' ' ' ILE . 83.4 mt -65.04 -37.5 80.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.042 0.448 . . . . 0.36 110.261 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 225' ' ' CYS . 78.6 t -60.58 -48.18 89.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.562 -0.745 . . . . 0.3 111.075 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.451 ' HZ3' ' HB3' ' A' ' 226' ' ' LEU . 1.8 m-90 -71.85 -40.26 69.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.015 0.436 . . . . 0.59 110.634 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.15 -8.16 7.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.808 -0.633 . . . . 0.29 111.581 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 232' ' ' VAL . 63.3 t -118.12 -1.82 9.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.794 0.807 . . . . 0.51 110.279 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -117.96 -2.17 11.34 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.263 -1.014 . . . . 0.52 108.263 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.8 mp -119.99 8.3 11.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 113.801 -1.545 . . . . 0.6 107.956 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 1.3 mptt . . . . . 0 N--CA 1.452 -0.355 0 CA-C-N 114.688 -1.142 . . . . 0.82 111.018 -178.529 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.429 ' HA ' HG12 ' A' ' 227' ' ' ILE . 2.7 pp . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 121.136 0.494 . . . . 0.51 110.184 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.428 ' N ' HD12 ' A' ' 224' ' ' ILE . 19.0 m -66.63 -34.42 77.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.576 -0.738 . . . . 1.36 110.276 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.45 -53.07 21.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.672 -0.695 . . . . 0.51 111.733 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.518 HG13 ' N ' ' A' ' 228' ' ' ILE . 10.9 pt -55.19 -36.2 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.154 0.427 . . . . 0.46 112.154 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.518 ' N ' HG13 ' A' ' 227' ' ' ILE . 81.0 mt -62.44 -37.75 79.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.109 0.48 . . . . 0.36 110.438 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 67.8 t -59.1 -50.01 81.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.46 -0.791 . . . . 0.3 111.063 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 3.1 m-90 -71.77 -36.39 70.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.59 110.901 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -65.28 -7.04 11.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.648 -0.705 . . . . 0.29 111.604 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 232' ' ' VAL . 71.6 t -117.87 -0.78 8.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.892 0.854 . . . . 0.51 109.953 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.01 -3.56 11.12 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.19 -1.041 . . . . 0.52 108.19 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 7.5 mp -120.02 9.03 11.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 113.961 -1.472 . . . . 0.6 108.278 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.452 -0.362 0 CA-C-N 114.983 -1.008 . . . . 0.82 111.656 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.7 pp . . . . . 0 CA--C 1.521 -0.152 0 CA-C-O 121.163 0.506 . . . . 0.51 110.085 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.44 ' HA ' HD12 ' A' ' 228' ' ' ILE . 33.6 m -66.55 -34.83 78.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.708 -0.678 . . . . 1.36 110.273 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.1 mp -62.12 -55.23 30.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.688 -0.687 . . . . 0.51 111.687 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.521 HG13 ' N ' ' A' ' 228' ' ' ILE . 16.2 pt -55.67 -35.78 40.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.486 -0.325 . . . . 0.46 111.806 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.521 ' N ' HG13 ' A' ' 227' ' ' ILE . 83.8 mt -62.14 -39.67 84.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.149 0.5 . . . . 0.36 110.248 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 79.2 t -56.41 -48.25 80.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.485 -0.779 . . . . 0.3 110.663 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.418 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 3.0 m-90 -72.43 -39.79 67.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.003 -0.544 . . . . 0.59 110.861 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -67.14 -7.21 21.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.614 -0.721 . . . . 0.29 111.493 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 232' ' ' VAL . 62.8 t -117.96 -0.06 8.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.836 0.827 . . . . 0.51 109.95 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.18 -4.31 10.99 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.097 -1.075 . . . . 0.52 108.097 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.1 mp -119.94 9.45 11.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.873 -1.512 . . . . 0.6 108.342 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.452 -0.342 0 CA-C-N 114.884 -1.053 . . . . 0.82 111.039 -178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.498 ' HA ' HG12 ' A' ' 227' ' ' ILE . 2.6 pp . . . . . 0 N--CA 1.458 -0.073 0 CA-C-O 120.92 0.39 . . . . 0.51 110.416 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.448 ' N ' HD12 ' A' ' 224' ' ' ILE . 53.0 t -67.12 -35.41 79.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.509 . . . . 1.36 110.297 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 8.3 mp -71.41 -49.05 45.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.731 -0.668 . . . . 0.51 111.8 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.535 HG13 ' N ' ' A' ' 228' ' ' ILE . 12.5 pt -57.31 -36.1 51.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.668 -0.242 . . . . 0.46 111.572 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.535 ' N ' HG13 ' A' ' 227' ' ' ILE . 81.5 mt -63.14 -37.61 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.147 0.498 . . . . 0.36 110.165 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 225' ' ' CYS . 74.9 t -60.82 -47.99 90.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.524 -0.762 . . . . 0.3 110.949 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.42 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 2.2 m-90 -72.22 -40.94 67.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.049 0.452 . . . . 0.59 110.871 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -64.15 -7.73 9.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.672 -0.695 . . . . 0.29 111.562 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 232' ' ' VAL . 68.3 t -118.02 -0.71 8.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.769 0.795 . . . . 0.51 110.133 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.25 -3.99 10.98 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.127 -1.064 . . . . 0.52 108.127 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.4 mp -119.79 8.95 11.23 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 113.894 -1.503 . . . . 0.6 108.119 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.1 mptt . . . . . 0 N--CA 1.45 -0.426 0 CA-C-N 114.911 -1.041 . . . . 0.82 111.187 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.433 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.6 pp . . . . . 0 CA--C 1.524 -0.041 0 CA-C-O 120.93 0.395 . . . . 0.51 110.667 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.433 ' N ' HD12 ' A' ' 224' ' ' ILE . 51.5 t -67.36 -35.15 78.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 1.36 110.566 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 8.8 mp -67.1 -50.29 62.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.764 -0.653 . . . . 0.51 111.932 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.546 HG13 ' N ' ' A' ' 228' ' ' ILE . 10.2 pt -55.82 -36.22 42.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 111.593 0.22 . . . . 0.46 111.593 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.546 ' N ' HG13 ' A' ' 227' ' ' ILE . 75.2 mt -62.55 -37.97 80.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.052 0.453 . . . . 0.36 110.166 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 75.4 t -58.06 -48.05 85.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.492 -0.776 . . . . 0.3 110.673 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.428 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 2.5 m-90 -71.95 -38.85 69.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.082 -0.508 . . . . 0.59 110.522 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.6 -7.37 14.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.719 -0.673 . . . . 0.29 111.472 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 232' ' ' VAL . 68.0 t -117.57 -1.28 9.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.75 0.786 . . . . 0.51 109.938 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.28 -3.62 10.99 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.087 -1.079 . . . . 0.52 108.087 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.0 mp -120.17 12.3 11.81 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 113.994 -1.457 . . . . 0.6 108.413 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.448 -0.539 0 CA-C-N 115.104 -0.953 . . . . 0.82 110.713 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 112.436 -0.266 . . . . 11.27 112.436 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 68.4 m -144.77 135.67 24.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.734 0.302 . . . . 10.03 110.993 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 38.9 t80 60.87 101.08 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.948 -0.569 . . . . 10.18 111.142 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 55.8 m -117.83 -48.49 2.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 7.94 111.023 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 42.5 tpp -117.72 159.99 22.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.177 -0.465 . . . . 6.74 110.768 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . 0.513 ' ND2' ' H ' ' A' ' 211' ' ' THR . 4.4 p-10 -79.84 -155.57 0.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.347 -0.388 . . . . 4.91 111.195 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.94 -12.39 4.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.197 -0.456 . . . . 2.79 111.738 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.513 ' H ' ' ND2' ' A' ' 209' ' ' ASN . 84.8 m -52.79 -59.7 4.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.567 -0.288 . . . . 1.62 111.415 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 86.1 m -52.04 -29.81 22.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.344 -0.389 . . . . 1.3 111.895 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 46.4 t -52.09 -37.28 21.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.83 0.348 . . . . 1.41 110.656 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -83.48 -32.19 26.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.058 -0.519 . . . . 1.45 110.655 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.28 -42.46 80.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 116.214 -0.448 . . . . 0.91 110.162 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.425 ' O ' ' HG ' ' A' ' 220' ' ' LEU . 51.7 m -57.8 -35.38 70.75 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.411 -0.589 . . . . 1.35 109.411 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 89.9 t -76.48 -30.05 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 115.294 -0.866 . . . . 0.48 110.468 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -58.75 -42.93 90.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.573 -0.739 . . . . 0.27 110.723 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 223' ' ' VAL . 22.1 t -66.52 -41.41 88.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.737 -0.665 . . . . 0.27 111.238 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 216' ' ' SER . 11.1 mt -53.21 -42.51 66.39 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.826 0.346 . . . . 0.27 110.46 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 39.5 t -54.4 -41.49 69.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.846 -0.616 . . . . 1.14 109.887 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.4 -36.33 68.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.081 -0.508 . . . . 0.38 110.671 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 219' ' ' VAL . 90.3 t -59.33 -54.08 39.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.183 -0.462 . . . . 0.49 111.363 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.478 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.7 pp -58.07 -31.52 41.69 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 121.059 0.456 . . . . 0.51 110.232 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.478 ' N ' HD12 ' A' ' 224' ' ' ILE . 54.8 m -66.99 -34.57 78.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.817 -0.629 . . . . 1.36 110.288 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 6.2 mp -69.12 -52.47 27.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.661 -0.7 . . . . 0.51 111.921 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.527 HG13 ' N ' ' A' ' 228' ' ' ILE . 9.9 pt -53.58 -36.0 27.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 111.945 0.35 . . . . 0.46 111.945 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.527 ' N ' HG13 ' A' ' 227' ' ' ILE . 84.2 mt -61.7 -37.33 77.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.162 0.506 . . . . 0.36 110.366 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 75.1 t -61.96 -49.05 85.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.45 -0.795 . . . . 0.3 111.268 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -71.61 -37.11 70.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.161 0.505 . . . . 0.59 110.951 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -62.45 -7.18 4.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.573 -0.74 . . . . 0.29 111.801 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 232' ' ' VAL . 78.0 t -117.84 -1.44 9.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.683 0.754 . . . . 0.51 110.283 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.15 -3.69 11.05 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.073 -1.084 . . . . 0.52 108.073 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 7.7 mp -120.07 10.57 11.47 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 113.84 -1.527 . . . . 0.6 108.343 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.2 mptt -114.92 3.03 14.45 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.019 -0.992 . . . . 0.82 111.472 -178.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.451 ' N ' HG11 ' A' ' 240' ' ' VAL . . . 149.09 54.42 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.637 -0.792 . . . . 1.97 112.469 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -74.62 -44.6 49.82 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.461 -0.37 . . . . 4.0 111.187 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 31.1 t -159.31 -65.84 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.507 -0.315 . . . . 5.29 111.379 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 50.8 mtm -127.98 54.24 1.73 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.284 -0.416 . . . . 6.96 111.066 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.451 HG11 ' N ' ' A' ' 236' ' ' GLY . 2.7 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.348 -0.834 . . . . 8.12 111.313 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 112.546 -0.221 . . . . 11.27 112.546 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 54.7 m 55.98 37.22 28.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 10.03 110.967 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -73.84 147.55 43.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 10.18 111.017 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 27.3 m 58.56 95.6 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.118 -0.492 . . . . 7.94 111.303 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 50.3 tpp -83.87 74.16 10.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.159 -0.473 . . . . 6.74 110.682 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -165.35 -67.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.935 -0.575 . . . . 4.91 110.666 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.57 -10.71 57.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.917 -0.583 . . . . 2.79 110.839 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 98.9 m -55.86 -52.03 65.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.966 -0.561 . . . . 1.62 111.26 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.463 ' HA ' HD13 ' A' ' 215' ' ' ILE . 11.4 m -51.97 -28.46 16.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.205 -0.452 . . . . 1.3 111.619 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.86 -40.08 60.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.777 0.322 . . . . 1.41 110.571 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 49.4 m95 -74.98 -34.72 62.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.446 . . . . 1.45 110.053 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.463 HD13 ' HA ' ' A' ' 212' ' ' THR . 1.8 mp -57.85 -39.9 73.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 116.038 -0.528 . . . . 0.91 109.833 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 46.2 t -60.57 -35.2 75.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.265 -0.643 . . . . 1.35 109.265 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 87.4 t -75.5 -29.94 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 115.244 -0.889 . . . . 0.48 110.01 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 215' ' ' ILE . . . -59.32 -43.98 92.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.533 -0.758 . . . . 0.27 110.716 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 223' ' ' VAL . 23.8 t -64.68 -40.04 87.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.611 -0.722 . . . . 0.27 111.317 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 9.9 mt -54.6 -41.97 70.56 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.866 0.365 . . . . 0.27 110.496 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.488 ' O ' HG13 ' A' ' 224' ' ' ILE . 51.2 m -54.29 -41.51 68.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.875 -0.602 . . . . 1.14 109.892 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.422 ' O ' HD13 ' A' ' 226' ' ' LEU . . . -72.95 -36.26 67.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.941 -0.572 . . . . 0.38 110.729 178.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 219' ' ' VAL . 74.9 t -57.27 -48.11 83.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.853 -0.612 . . . . 0.49 112.027 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 221' ' ' SER . 2.2 pp -56.39 -35.83 44.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.958 0.409 . . . . 0.51 110.753 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 51.1 t -66.46 -37.47 85.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.058 -0.519 . . . . 1.36 110.56 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 222' ' ' ALA . 9.6 mp -66.17 -52.53 47.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.895 -0.593 . . . . 0.51 111.655 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.514 HG13 ' N ' ' A' ' 228' ' ' ILE . 17.6 pt -55.46 -35.81 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.638 -0.256 . . . . 0.46 111.655 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.514 ' N ' HG13 ' A' ' 227' ' ' ILE . 82.9 mt -62.24 -39.06 82.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.08 0.467 . . . . 0.36 110.271 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 77.7 t -57.09 -49.95 77.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.499 -0.773 . . . . 0.3 110.794 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -72.45 -37.93 68.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.59 110.882 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -64.93 -7.16 10.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.642 -0.708 . . . . 0.29 111.793 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 232' ' ' VAL . 74.6 t -117.77 -0.95 8.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.836 0.827 . . . . 0.51 110.107 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.04 -4.49 11.03 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.206 -1.035 . . . . 0.52 108.206 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 6.8 mp -119.93 10.77 11.62 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 113.843 -1.526 . . . . 0.6 108.319 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.1 mptt -114.69 -14.85 12.0 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.061 -0.972 . . . . 0.82 111.29 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 150.56 59.02 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.713 -0.756 . . . . 1.97 112.65 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -67.59 -34.62 77.39 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.87 0.367 . . . . 4.0 110.465 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 41.5 t -155.46 -73.23 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.968 -0.56 . . . . 5.29 110.558 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 51.1 mtm -136.49 58.11 1.75 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.067 -0.515 . . . . 6.96 110.659 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 240' ' ' VAL . 15.8 m . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.602 -0.713 . . . . 8.12 111.427 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 112.48 -0.248 . . . . 11.27 112.48 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 81.1 p -148.06 166.27 28.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.82 0.343 . . . . 10.03 110.905 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -125.64 20.53 7.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 10.18 110.955 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 73.4 m -123.07 -69.34 0.83 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.178 -0.464 . . . . 7.94 111.057 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 54.8 ttm -145.47 -71.86 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 6.74 110.717 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -171.95 -82.87 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.243 -0.435 . . . . 4.91 110.988 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.37 6.68 0.66 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 2.79 110.976 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 88.9 m -64.61 -54.01 38.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.14 -0.482 . . . . 1.62 111.225 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 19.5 m -52.14 -23.06 4.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.079 -0.51 . . . . 1.3 111.747 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 64.3 t -54.27 -40.54 48.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.689 0.281 . . . . 1.41 111.057 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -83.22 -32.19 26.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.304 -0.407 . . . . 1.45 110.734 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 1.8 mp -57.03 -37.78 56.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 110.006 -0.368 . . . . 0.91 110.006 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 43.8 t -60.4 -34.98 74.7 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.208 -0.664 . . . . 1.35 109.208 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.63 -31.38 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.32 -0.855 . . . . 0.48 110.047 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 215' ' ' ILE . . . -58.18 -40.17 80.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.411 -0.813 . . . . 0.27 110.674 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 223' ' ' VAL . 20.8 t -66.85 -42.73 89.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.562 -0.745 . . . . 0.27 111.244 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.97 -44.16 63.89 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.974 0.416 . . . . 0.27 110.507 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 49.2 m -54.06 -41.21 67.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.714 -0.676 . . . . 1.14 110.077 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.423 ' O ' HD13 ' A' ' 226' ' ' LEU . . . -72.33 -36.11 68.77 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.036 -0.529 . . . . 0.38 110.636 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 219' ' ' VAL . 95.4 t -58.85 -53.43 47.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.112 -0.495 . . . . 0.49 111.496 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.469 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.6 pp -58.25 -31.33 42.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-O 120.991 0.424 . . . . 0.51 110.21 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.469 ' N ' HD12 ' A' ' 224' ' ' ILE . 58.2 m -66.96 -34.38 77.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.88 -0.6 . . . . 1.36 110.26 178.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 222' ' ' ALA . 7.0 mp -70.91 -48.25 54.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.635 -0.712 . . . . 0.51 112.198 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.518 HG13 ' N ' ' A' ' 228' ' ' ILE . 12.9 pt -56.95 -36.16 49.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 111.98 0.363 . . . . 0.46 111.98 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.518 ' N ' HG13 ' A' ' 227' ' ' ILE . 81.3 mt -61.62 -37.65 78.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.187 0.518 . . . . 0.36 110.3 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 79.6 t -58.68 -49.86 81.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.444 -0.798 . . . . 0.3 111.036 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.403 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 2.1 m-90 -72.05 -38.92 69.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.07 0.462 . . . . 0.59 110.863 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -64.16 -8.08 11.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.705 -0.68 . . . . 0.29 111.657 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 232' ' ' VAL . 65.4 t -117.95 -0.44 8.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.9 0.857 . . . . 0.51 110.042 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 237' ' ' TYR . . . -118.22 -2.93 11.08 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.14 -1.059 . . . . 0.52 108.14 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 8.0 mp -120.02 8.74 11.06 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 113.917 -1.492 . . . . 0.6 108.09 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.2 mptt -115.08 3.15 14.35 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.712 -1.131 . . . . 0.82 111.28 -178.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 166.49 47.8 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.634 -0.793 . . . . 1.97 112.669 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.453 ' HB3' ' O ' ' A' ' 233' ' ' ALA . 14.2 p90 -70.97 -2.26 14.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.818 0.342 . . . . 4.0 111.095 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 47.9 t -75.57 -12.08 60.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.279 -0.419 . . . . 5.29 110.919 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 55.5 mtt -116.96 37.07 3.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 6.96 111.056 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.406 ' H ' HG22 ' A' ' 240' ' ' VAL . 2.2 m . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.382 -0.818 . . . . 8.12 111.298 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 112.511 -0.236 . . . . 11.27 112.511 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 74.7 p -105.81 88.81 2.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.92 0.391 . . . . 10.03 110.732 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -88.67 18.04 5.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 10.18 111.114 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 48.4 p 49.64 45.77 24.15 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.957 -0.565 . . . . 7.94 111.488 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 56.9 ttp -84.1 145.53 28.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 6.74 110.968 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -118.07 151.85 36.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.447 . . . . 4.91 110.838 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.9 86.61 0.24 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.127 -0.488 . . . . 2.79 111.245 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.406 ' O ' HD13 ' A' ' 215' ' ' ILE . 59.0 m -97.45 -64.11 1.07 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.072 -0.513 . . . . 1.62 111.16 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.434 ' HA ' ' HB ' ' A' ' 215' ' ' ILE . 30.5 m -51.89 -26.66 10.67 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.192 -0.458 . . . . 1.3 110.764 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 50.2 t -55.43 -41.65 63.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.8 -0.636 . . . . 1.41 110.571 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -83.55 -28.9 28.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.982 -0.554 . . . . 1.45 110.871 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.434 ' HB ' ' HA ' ' A' ' 212' ' ' THR . 1.7 mp -55.19 -43.24 69.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.488 -0.324 . . . . 0.91 110.348 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 48.0 t -57.7 -35.96 71.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.387 0.613 . . . . 1.35 109.382 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 87.2 t -75.33 -30.1 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 115.19 -0.914 . . . . 0.48 110.16 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 215' ' ' ILE . . . -58.38 -39.09 78.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.598 -0.728 . . . . 0.27 110.669 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 15.1 t -69.02 -38.1 77.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.518 -0.765 . . . . 0.27 111.114 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 13.8 mt -57.69 -47.35 82.57 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 120.851 0.358 . . . . 0.27 110.378 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 50.4 m -54.45 -36.06 63.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.832 -0.622 . . . . 1.14 110.061 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.492 ' O ' HD13 ' A' ' 226' ' ' LEU . . . -72.6 -45.47 58.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.974 -0.557 . . . . 0.38 110.738 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 69.4 t -57.31 -50.79 75.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.03 -0.532 . . . . 0.49 111.509 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.418 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.7 pp -60.69 -31.82 50.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.011 0.434 . . . . 0.51 110.244 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.418 ' N ' HD12 ' A' ' 224' ' ' ILE . 35.0 t -66.94 -35.11 79.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.963 -0.562 . . . . 1.36 110.147 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.492 HD13 ' O ' ' A' ' 222' ' ' ALA . 7.4 mp -63.64 -50.5 69.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.575 -0.739 . . . . 0.51 111.877 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.514 HG13 ' N ' ' A' ' 228' ' ' ILE . 11.5 pt -59.24 -35.99 60.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.798 -0.183 . . . . 0.46 111.484 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.514 ' N ' HG13 ' A' ' 227' ' ' ILE . 82.7 mt -61.6 -37.79 78.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.194 0.521 . . . . 0.36 110.223 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 65.4 t -56.79 -48.85 80.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.453 -0.794 . . . . 0.3 110.873 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.412 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 2.4 m-90 -72.36 -40.23 67.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.047 -0.524 . . . . 0.59 110.845 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -66.52 -7.27 18.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.7 -0.682 . . . . 0.29 111.616 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 232' ' ' VAL . 71.3 t -118.0 -0.06 8.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.931 0.872 . . . . 0.51 109.983 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.29 -3.85 10.97 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.123 -1.065 . . . . 0.52 108.123 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.3 mp -119.97 9.92 11.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 113.937 -1.483 . . . . 0.6 108.273 178.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.2 mptt -114.99 -56.33 2.39 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.02 -0.991 . . . . 0.82 111.832 -178.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -138.18 39.66 1.56 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 121.035 -0.602 . . . . 1.97 112.891 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -62.35 -18.52 61.66 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.771 0.32 . . . . 4.0 111.27 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 41.6 t -82.6 -34.72 27.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.401 -0.363 . . . . 5.29 111.127 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 71.0 mtm -103.1 40.46 1.39 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.279 -0.419 . . . . 6.96 111.08 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.434 HG22 ' H ' ' A' ' 240' ' ' VAL . 2.4 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.025 -0.988 . . . . 8.12 111.303 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 112.563 -0.215 . . . . 11.27 112.563 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.406 ' HB3' ' HG3' ' A' ' 208' ' ' MET . 48.7 m -67.98 157.71 34.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.703 0.287 . . . . 10.03 110.868 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -100.2 118.52 36.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.321 -0.4 . . . . 10.18 111.03 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 24.3 m 59.65 -90.33 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.045 -0.525 . . . . 7.94 111.243 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.406 ' HG3' ' HB3' ' A' ' 205' ' ' SER . 24.5 mmt 54.23 44.84 28.48 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.318 -0.401 . . . . 6.74 111.365 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -68.02 114.36 6.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.444 -0.344 . . . . 4.91 110.788 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -79.09 -14.74 58.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 2.79 111.32 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 88.8 m -56.05 -52.38 64.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.225 -0.443 . . . . 1.62 111.309 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.439 ' HA ' HD13 ' A' ' 215' ' ' ILE . 36.3 m -52.96 -28.3 23.09 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.077 -0.51 . . . . 1.3 111.882 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 53.6 t -54.35 -39.5 44.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.871 0.367 . . . . 1.41 110.965 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -83.43 -24.99 31.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.07 -0.513 . . . . 1.45 110.945 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 212' ' ' THR . 1.7 mp -56.52 -42.19 74.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.58 -0.282 . . . . 0.91 110.527 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 80.5 p -57.63 -35.32 70.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.4 0.619 . . . . 1.35 109.365 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 92.7 t -75.25 -32.48 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.186 -0.915 . . . . 0.48 110.058 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.33 91.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.44 -0.8 . . . . 0.27 110.572 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 24.3 t -63.73 -37.32 79.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.705 -0.679 . . . . 0.27 110.732 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 13.0 mt -57.63 -41.44 81.36 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.009 0.433 . . . . 0.27 109.983 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.417 ' O ' HG13 ' A' ' 224' ' ' ILE . 45.7 t -54.14 -37.63 64.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.603 -0.726 . . . . 1.14 109.741 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.491 ' O ' HD13 ' A' ' 226' ' ' LEU . . . -72.74 -40.19 66.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.788 -0.642 . . . . 0.38 110.347 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 87.8 t -57.24 -53.48 43.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 115.863 -0.608 . . . . 0.49 111.7 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.438 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.6 pp -56.48 -33.86 39.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.023 0.439 . . . . 0.51 110.453 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.438 ' N ' HD12 ' A' ' 224' ' ' ILE . 38.6 t -67.55 -35.01 78.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.972 -0.558 . . . . 1.36 110.328 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.491 HD13 ' O ' ' A' ' 222' ' ' ALA . 7.3 mp -68.31 -49.87 57.4 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.555 -0.748 . . . . 0.51 112.214 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.52 HG13 ' N ' ' A' ' 228' ' ' ILE . 4.4 pt -53.76 -36.25 29.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.593 0.235 . . . . 0.46 111.433 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.52 ' N ' HG13 ' A' ' 227' ' ' ILE . 65.6 mt -66.22 -38.0 80.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.073 0.463 . . . . 0.36 110.146 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 225' ' ' CYS . 79.0 t -59.05 -46.05 92.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.646 -0.706 . . . . 0.3 110.717 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.446 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 1.9 m-90 -71.95 -41.66 67.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.08 0.467 . . . . 0.59 110.2 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -64.79 -8.3 14.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.66 -0.7 . . . . 0.29 111.295 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.499 HG12 ' O ' ' A' ' 232' ' ' VAL . 60.7 t -118.31 -1.06 8.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.849 0.833 . . . . 0.51 109.9 179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 237' ' ' TYR . . . -118.09 -1.97 11.31 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.272 -1.01 . . . . 0.52 108.272 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 8.6 mp -120.46 7.78 10.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 113.907 -1.497 . . . . 0.6 107.805 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.3 mptt -115.56 -21.69 9.61 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.852 -1.067 . . . . 0.82 112.009 -178.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -148.93 25.4 1.29 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.515 -0.85 . . . . 1.97 113.169 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.537 ' HB3' ' O ' ' A' ' 233' ' ' ALA . 38.2 p90 -67.05 -7.49 23.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.727 0.298 . . . . 4.0 110.945 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 52.1 m -84.95 -38.21 19.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 5.29 111.077 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 85.3 mtp -94.13 35.65 1.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 6.96 111.133 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.435 HG22 ' H ' ' A' ' 240' ' ' VAL . 2.3 m . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.148 -0.929 . . . . 8.12 111.325 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.462 -0.255 . . . . 11.27 112.462 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 50.1 m -113.49 138.59 49.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.829 0.347 . . . . 10.03 110.917 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -107.86 30.17 6.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.04 -0.527 . . . . 10.18 110.75 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 60.3 p -67.33 -16.41 64.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 7.94 111.053 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 65.8 mtm -127.7 84.15 2.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 6.74 110.818 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -60.64 131.24 50.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 4.91 110.689 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -83.94 21.51 1.31 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 2.79 110.933 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.44 ' O ' HD13 ' A' ' 215' ' ' ILE . 90.4 m -54.92 -55.52 29.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.396 . . . . 1.62 110.764 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.411 ' HA ' ' HB ' ' A' ' 215' ' ' ILE . 17.5 m -53.39 -27.06 22.06 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.935 -0.575 . . . . 1.3 111.55 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 47.4 t -59.19 -38.66 75.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.837 0.351 . . . . 1.41 110.64 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -82.72 -23.37 34.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.194 -0.457 . . . . 1.45 110.42 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 211' ' ' THR . 1.7 mp -65.26 -48.43 83.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.208 -0.451 . . . . 0.91 110.255 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 81.7 p -58.4 -36.07 73.0 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.298 -0.63 . . . . 1.35 109.298 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 91.4 t -75.46 -29.89 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.315 -0.857 . . . . 0.48 109.904 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.2 -38.83 90.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.344 -0.843 . . . . 0.27 110.609 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 223' ' ' VAL . 21.6 t -69.46 -34.47 62.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.658 -0.701 . . . . 0.27 111.415 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 14.0 mt -59.59 -48.71 80.59 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 120.83 0.347 . . . . 0.27 110.692 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 224' ' ' ILE . 94.5 p -54.82 -36.19 64.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.181 0.515 . . . . 1.14 109.799 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.49 ' O ' HD13 ' A' ' 226' ' ' LEU . . . -73.0 -37.93 66.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.701 -0.681 . . . . 0.38 110.74 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 219' ' ' VAL . 39.6 t -58.99 -52.56 59.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.093 -0.503 . . . . 0.49 111.817 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.7 pp -55.97 -33.35 35.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.909 0.385 . . . . 0.51 110.471 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.475 ' N ' HD12 ' A' ' 224' ' ' ILE . 51.2 t -67.4 -34.94 78.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.021 -0.536 . . . . 1.36 110.461 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 222' ' ' ALA . 8.2 mp -70.21 -51.91 27.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.643 -0.708 . . . . 0.51 112.105 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.512 HG13 ' N ' ' A' ' 228' ' ' ILE . 4.8 pt -53.59 -36.24 27.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 111.729 0.27 . . . . 0.46 111.729 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.512 ' N ' HG13 ' A' ' 227' ' ' ILE . 83.4 mt -65.04 -37.5 80.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.042 0.448 . . . . 0.36 110.261 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 225' ' ' CYS . 78.6 t -60.58 -48.18 89.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.562 -0.745 . . . . 0.3 111.075 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.451 ' HZ3' ' HB3' ' A' ' 226' ' ' LEU . 1.8 m-90 -71.85 -40.26 69.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.015 0.436 . . . . 0.59 110.634 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.15 -8.16 7.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.808 -0.633 . . . . 0.29 111.581 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 232' ' ' VAL . 63.3 t -118.12 -1.82 9.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.794 0.807 . . . . 0.51 110.279 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -117.96 -2.17 11.34 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.263 -1.014 . . . . 0.52 108.263 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.8 mp -119.99 8.3 11.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 113.801 -1.545 . . . . 0.6 107.956 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -114.81 36.66 3.74 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.688 -1.142 . . . . 0.82 111.018 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 163.21 0.67 0.05 OUTLIER Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.752 -0.737 . . . . 1.97 113.075 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.91 -23.15 27.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.787 0.327 . . . . 4.0 110.676 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 47.6 t -71.34 -17.37 62.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.017 -0.538 . . . . 5.29 110.964 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 66.8 mtm -111.91 40.41 2.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.391 -0.368 . . . . 6.96 111.252 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.17 -0.919 . . . . 8.12 111.125 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 112.411 -0.275 . . . . 11.27 112.411 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 59.5 m -150.86 143.62 24.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 10.03 110.998 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -151.53 13.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 10.18 110.667 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 60.1 m -126.0 94.08 4.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.116 -0.493 . . . . 7.94 111.097 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -75.62 -170.17 1.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 6.74 110.865 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -55.19 -74.3 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.245 -0.434 . . . . 4.91 110.98 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.7 6.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 2.79 110.818 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 99.9 m -60.6 -53.9 51.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.442 . . . . 1.62 111.009 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.494 ' HA ' HD13 ' A' ' 215' ' ' ILE . 15.4 m -53.2 -23.95 9.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 1.3 111.711 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 58.7 t -58.96 -36.88 64.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.916 0.388 . . . . 1.41 110.512 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -80.81 -31.05 35.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.035 -0.53 . . . . 1.45 110.306 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' A' ' 212' ' ' THR . 1.8 mp -58.62 -42.9 86.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.258 -0.428 . . . . 0.91 110.098 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 46.9 t -60.9 -35.58 77.02 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.223 -0.658 . . . . 1.35 109.223 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 86.3 t -73.59 -29.41 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.276 -0.875 . . . . 0.48 110.04 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 215' ' ' ILE . . . -54.34 -46.69 72.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.514 -0.766 . . . . 0.27 110.87 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 19.5 t -65.67 -41.09 89.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.974 -0.557 . . . . 0.27 111.058 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 11.8 mt -54.3 -41.18 68.65 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 120.901 0.382 . . . . 0.27 110.197 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.418 ' O ' HG13 ' A' ' 224' ' ' ILE . 53.9 m -54.15 -41.61 68.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.724 -0.671 . . . . 1.14 110.243 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.4 -39.54 67.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.021 -0.536 . . . . 0.38 110.691 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 97.6 t -59.2 -53.1 52.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.114 -0.494 . . . . 0.49 111.279 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.429 ' HA ' HG12 ' A' ' 227' ' ' ILE . 2.7 pp -58.55 -31.85 44.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.136 0.494 . . . . 0.51 110.184 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.428 ' N ' HD12 ' A' ' 224' ' ' ILE . 19.0 m -66.63 -34.42 77.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.576 -0.738 . . . . 1.36 110.276 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.45 -53.07 21.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.672 -0.695 . . . . 0.51 111.733 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.518 HG13 ' N ' ' A' ' 228' ' ' ILE . 10.9 pt -55.19 -36.2 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.154 0.427 . . . . 0.46 112.154 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.518 ' N ' HG13 ' A' ' 227' ' ' ILE . 81.0 mt -62.44 -37.75 79.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.109 0.48 . . . . 0.36 110.438 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 67.8 t -59.1 -50.01 81.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.46 -0.791 . . . . 0.3 111.063 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 3.1 m-90 -71.77 -36.39 70.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.59 110.901 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -65.28 -7.04 11.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.648 -0.705 . . . . 0.29 111.604 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 232' ' ' VAL . 71.6 t -117.87 -0.78 8.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.892 0.854 . . . . 0.51 109.953 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.01 -3.56 11.12 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.19 -1.041 . . . . 0.52 108.19 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 7.5 mp -120.02 9.03 11.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 113.961 -1.472 . . . . 0.6 108.278 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 0.9 OUTLIER -115.14 46.96 1.35 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 114.983 -1.008 . . . . 0.82 111.656 -178.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 145.97 -1.13 0.9 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.497 -0.858 . . . . 1.97 112.959 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.95 -23.57 14.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.901 0.382 . . . . 4.0 110.864 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 43.3 t -68.67 -7.47 33.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 5.29 111.071 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 48.8 mtm -124.64 35.83 4.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.428 -0.351 . . . . 6.96 111.198 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.427 HG22 ' H ' ' A' ' 240' ' ' VAL . 2.4 m . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.504 -0.76 . . . . 8.12 111.222 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 N-CA-C 112.444 -0.262 . . . . 11.27 112.444 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 47.2 t 61.12 -84.28 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.738 0.304 . . . . 10.03 111.179 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -86.05 93.72 9.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.881 0.372 . . . . 10.18 110.818 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 87.7 m -154.67 -66.59 0.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 7.94 111.035 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 91.8 mmm 64.18 118.4 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.145 -0.48 . . . . 6.74 111.317 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -120.16 112.95 19.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 4.91 110.937 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -176.21 7.5 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.014 -0.539 . . . . 2.79 110.63 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.425 ' O ' HD13 ' A' ' 215' ' ' ILE . 60.4 m -53.28 -56.2 18.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 1.62 111.646 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 14.9 m -52.19 -26.3 11.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.446 . . . . 1.3 112.036 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 59.0 t -61.05 -40.09 84.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.822 0.344 . . . . 1.41 110.841 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 48.7 m95 -78.8 -28.0 44.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.176 -0.466 . . . . 1.45 110.058 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.434 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 1.7 mp -59.84 -41.12 84.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.028 -0.533 . . . . 0.91 110.279 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 49.4 m -60.11 -35.7 75.82 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.27 -0.641 . . . . 1.35 109.27 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 98.4 t -74.11 -29.9 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 115.188 -0.914 . . . . 0.48 110.196 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 215' ' ' ILE . . . -55.7 -41.89 74.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.568 -0.742 . . . . 0.27 110.842 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 24.9 t -67.46 -41.98 86.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.719 -0.673 . . . . 0.27 111.214 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 13.6 mt -52.51 -44.38 65.66 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.965 0.412 . . . . 0.27 110.428 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.409 ' O ' HG13 ' A' ' 224' ' ' ILE . 56.6 m -54.17 -41.1 68.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.766 -0.652 . . . . 1.14 110.155 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.09 -36.9 69.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 0.38 110.847 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 76.7 t -60.94 -53.07 54.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-N 116.151 -0.477 . . . . 0.49 111.358 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 225' ' ' CYS . 2.7 pp -59.74 -31.8 48.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.163 0.506 . . . . 0.51 110.085 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.44 ' HA ' HD12 ' A' ' 228' ' ' ILE . 33.6 m -66.55 -34.83 78.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.708 -0.678 . . . . 1.36 110.273 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.1 mp -62.12 -55.23 30.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.688 -0.687 . . . . 0.51 111.687 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.521 HG13 ' N ' ' A' ' 228' ' ' ILE . 16.2 pt -55.67 -35.78 40.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.486 -0.325 . . . . 0.46 111.806 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.521 ' N ' HG13 ' A' ' 227' ' ' ILE . 83.8 mt -62.14 -39.67 84.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.149 0.5 . . . . 0.36 110.248 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 79.2 t -56.41 -48.25 80.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.485 -0.779 . . . . 0.3 110.663 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.418 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 3.0 m-90 -72.43 -39.79 67.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.003 -0.544 . . . . 0.59 110.861 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -67.14 -7.21 21.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.614 -0.721 . . . . 0.29 111.493 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 232' ' ' VAL . 62.8 t -117.96 -0.06 8.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.836 0.827 . . . . 0.51 109.95 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.18 -4.31 10.99 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.097 -1.075 . . . . 0.52 108.097 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.1 mp -119.94 9.45 11.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.873 -1.512 . . . . 0.6 108.342 178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 0.8 OUTLIER -114.76 -1.59 13.21 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.884 -1.053 . . . . 0.82 111.039 -178.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 134.77 58.07 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.875 -0.679 . . . . 1.97 112.291 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.416 ' HA ' HG13 ' A' ' 240' ' ' VAL . 30.2 p90 -66.97 -4.2 9.01 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.339 -0.43 . . . . 4.0 111.2 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 53.9 m -79.95 -33.38 39.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.306 -0.407 . . . . 5.29 111.37 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 55.5 mtm -125.53 42.58 3.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.407 -0.36 . . . . 6.96 111.567 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.448 HG22 ' H ' ' A' ' 240' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.105 -0.95 . . . . 8.12 111.165 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.576 -0.21 . . . . 11.27 112.576 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 53.9 m -140.77 130.9 24.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.762 0.315 . . . . 10.03 110.903 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -136.12 129.04 31.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 10.18 110.959 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.607 HG22 ' HG2' ' A' ' 208' ' ' MET . 27.0 m -101.14 141.05 34.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.073 -0.512 . . . . 7.94 110.901 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.607 ' HG2' HG22 ' A' ' 207' ' ' THR . 25.3 mmt 63.07 -82.21 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.166 -0.47 . . . . 6.74 111.195 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -60.95 143.12 55.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.92 0.391 . . . . 4.91 110.965 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -167.28 12.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.995 -0.548 . . . . 2.79 110.553 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 91.4 m -57.77 -53.11 61.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.046 -0.524 . . . . 1.62 111.276 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 12.9 m -53.39 -27.23 22.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 1.3 111.805 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.18 -34.38 56.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.87 0.367 . . . . 1.41 110.533 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -82.03 -29.6 31.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.07 -0.514 . . . . 1.45 110.111 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.433 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 1.7 mp -61.37 -45.24 99.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.058 -0.519 . . . . 0.91 110.021 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.417 ' O ' ' HG ' ' A' ' 220' ' ' LEU . 78.3 p -59.04 -34.93 72.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.18 -0.674 . . . . 1.35 109.18 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 87.4 t -74.9 -29.65 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.293 -0.867 . . . . 0.48 110.221 178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 215' ' ' ILE . . . -59.0 -45.38 90.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.463 -0.79 . . . . 0.27 110.814 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 223' ' ' VAL . 19.5 t -64.35 -41.01 91.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.672 -0.695 . . . . 0.27 111.416 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 216' ' ' SER . 11.3 mt -52.71 -43.31 65.56 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.819 0.342 . . . . 0.27 110.599 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.42 ' O ' HG13 ' A' ' 224' ' ' ILE . 55.5 m -54.42 -41.35 69.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.947 -0.57 . . . . 1.14 110.133 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.427 ' O ' HD13 ' A' ' 226' ' ' LEU . . . -72.66 -38.01 67.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.036 -0.529 . . . . 0.38 110.903 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 219' ' ' VAL . 92.4 t -61.2 -51.68 70.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 115.996 -0.547 . . . . 0.49 111.843 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.498 ' HA ' HG12 ' A' ' 227' ' ' ILE . 2.6 pp -56.11 -32.57 34.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.92 0.39 . . . . 0.51 110.416 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.448 ' N ' HD12 ' A' ' 224' ' ' ILE . 53.0 t -67.12 -35.41 79.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.509 . . . . 1.36 110.297 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 222' ' ' ALA . 8.3 mp -71.41 -49.05 45.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.731 -0.668 . . . . 0.51 111.8 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.535 HG13 ' N ' ' A' ' 228' ' ' ILE . 12.5 pt -57.31 -36.1 51.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.668 -0.242 . . . . 0.46 111.572 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.535 ' N ' HG13 ' A' ' 227' ' ' ILE . 81.5 mt -63.14 -37.61 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.147 0.498 . . . . 0.36 110.165 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 225' ' ' CYS . 74.9 t -60.82 -47.99 90.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.524 -0.762 . . . . 0.3 110.949 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.42 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 2.2 m-90 -72.22 -40.94 67.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.049 0.452 . . . . 0.59 110.871 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 235' ' ' LYS . . . -64.15 -7.73 9.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.672 -0.695 . . . . 0.29 111.562 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 232' ' ' VAL . 68.3 t -118.02 -0.71 8.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.769 0.795 . . . . 0.51 110.133 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -118.25 -3.99 10.98 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.127 -1.064 . . . . 0.52 108.127 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.4 mp -119.79 8.95 11.23 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 113.894 -1.503 . . . . 0.6 108.119 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 231' ' ' ALA . 1.1 mptt -115.05 -7.12 12.52 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.911 -1.041 . . . . 0.82 111.187 -178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 165.65 -12.3 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.771 -0.728 . . . . 1.97 112.677 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 32.9 p90 34.21 35.3 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.614 0.598 . . . . 4.0 112.614 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 61.5 m -91.6 -31.49 15.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.374 -0.376 . . . . 5.29 111.125 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 62.7 mtt -109.34 37.12 2.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 6.96 110.974 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.463 -0.779 . . . . 8.12 111.198 179.963 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 112.571 -0.212 . . . . 11.27 112.571 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 43.6 t -132.19 -58.98 0.94 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.733 0.301 . . . . 10.03 110.951 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 55.02 81.37 0.11 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.144 -0.48 . . . . 10.18 111.107 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 73.5 p -108.63 47.9 0.89 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.081 -0.508 . . . . 7.94 111.2 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 10.8 tmm? -155.62 -51.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 6.74 110.713 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -88.23 1.17 55.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.485 . . . . 4.91 111.005 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -62.83 -19.84 64.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.434 . . . . 2.79 111.241 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 92.4 m -54.47 -56.07 22.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.32 -0.4 . . . . 1.62 110.957 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 13.5 m -53.66 -25.14 16.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.002 -0.544 . . . . 1.3 111.848 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 48.4 t -57.72 -37.62 60.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.799 0.333 . . . . 1.41 110.76 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' TRP . . . . . . . . . . . . . 62.2 m95 -81.84 -31.79 31.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.203 -0.453 . . . . 1.45 110.355 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.0 -40.21 62.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-N 116.263 -0.426 . . . . 0.91 110.02 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 61.9 m -58.42 -35.16 71.65 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.377 -0.601 . . . . 1.35 109.377 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 92.9 t -75.07 -29.89 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.481 -0.781 . . . . 0.48 110.151 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.14 -40.95 97.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.526 -0.761 . . . . 0.27 110.788 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 223' ' ' VAL . 21.1 t -66.08 -37.06 78.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.66 -0.7 . . . . 0.27 111.407 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 12.0 mt -55.92 -44.7 78.55 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 120.917 0.389 . . . . 0.27 110.458 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.477 ' O ' HG13 ' A' ' 224' ' ' ILE . 47.9 t -54.3 -39.41 66.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.794 -0.639 . . . . 1.14 110.219 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.417 ' O ' HD13 ' A' ' 226' ' ' LEU . . . -73.04 -39.31 66.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.978 -0.555 . . . . 0.38 110.851 178.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 219' ' ' VAL . 62.0 t -57.44 -50.45 76.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 115.948 -0.569 . . . . 0.49 112.018 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 221' ' ' SER . 2.6 pp -56.56 -33.26 39.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.93 0.395 . . . . 0.51 110.667 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.433 ' N ' HD12 ' A' ' 224' ' ' ILE . 51.5 t -67.36 -35.15 78.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 1.36 110.566 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 222' ' ' ALA . 8.8 mp -67.1 -50.29 62.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.764 -0.653 . . . . 0.51 111.932 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.546 HG13 ' N ' ' A' ' 228' ' ' ILE . 10.2 pt -55.82 -36.22 42.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 111.593 0.22 . . . . 0.46 111.593 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.546 ' N ' HG13 ' A' ' 227' ' ' ILE . 75.2 mt -62.55 -37.97 80.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.052 0.453 . . . . 0.36 110.166 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 75.4 t -58.06 -48.05 85.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.492 -0.776 . . . . 0.3 110.673 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.428 ' O ' ' HB2' ' A' ' 234' ' ' LEU . 2.5 m-90 -71.95 -38.85 69.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.082 -0.508 . . . . 0.59 110.522 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.6 -7.37 14.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.719 -0.673 . . . . 0.29 111.472 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 232' ' ' VAL . 68.0 t -117.57 -1.28 9.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.75 0.786 . . . . 0.51 109.938 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 237' ' ' TYR . . . -118.28 -3.62 10.99 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.087 -1.079 . . . . 0.52 108.087 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 230' ' ' TRP . 7.0 mp -120.17 12.3 11.81 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 113.994 -1.457 . . . . 0.6 108.413 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.06 50.26 0.94 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.104 -0.953 . . . . 0.82 110.713 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 136.94 14.23 0.88 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.606 -0.724 . . . . 1.97 112.266 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.458 ' HB2' ' O ' ' A' ' 233' ' ' ALA . 39.1 m-85 -127.66 -7.12 5.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.767 0.318 . . . . 4.0 111.066 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 11.2 t -102.43 -43.41 5.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 5.29 110.891 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 77.3 mtp -86.66 32.38 0.66 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.901 -0.59 . . . . 6.96 111.325 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.567 -0.73 . . . . 8.12 111.396 -179.986 . . . . . . . . 0 0 . 1 stop_ save_